Processing 00000000.tx.1: Tau Is Hyperphosphorylated in the Insulin-Like Growth Factor-I Null Brain Clara M. 

Phrase: "Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "Is"

Phrase: "Hyperphosphorylated"

Phrase: "in the Insulin-Like Growth Factor-I Null Brain Clara M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   791   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   791   C0441923:M+ [Intellectual Product]
   707   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   707   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
Processing 00000000.tx.2: Cheng, Victor Tseng, Jie Wang, Daniel Wang, Ludmila Matyakhina and Carolyn A. 

Phrase: "Cheng,"

Phrase: "Victor Tseng,"

Phrase: "Jie Wang,"

Phrase: "Daniel Wang,"

Phrase: "Ludmila Matyakhina"

Phrase: "and"

Phrase: "Carolyn A."
Processing 00000000.tx.3: Bondy Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892 Address all correspondence and requests for reprints to: Clara Cheng, Building 10/CRC 1-3330, 10 Center Drive, National Institutes of Health, Bethesda, Maryland 20892. 

Phrase: "Bondy Developmental Endocrinology Branch,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1253959:Branch [Body Part, Organ, or Organ Component]
   812   C1881507:Branch [Chemical Viewed Structurally]
   812   C2700383:Branch [Plant]
   812   C2826234:BRANCH [Intellectual Product]

Phrase: "National Institute of Child Health and Human Development,"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
  1000   C1513896:National Institute of Child Health and Human Development [Health Care Related Organization]
   855   C0027468:national institute health [Health Care Related Organization]
   850   C0008071:Child Development [Organism Function]
   836   C0680063:Human, Child [Family Group]
           CHILD
   812   C0008078:Child Health [Health Care Activity]
   812   C0020119:Human Development [Physiologic Function]
   793   C0008059:Child [Age Group]
   793   C0018684:Health [Idea or Concept]
   793   C0021622:institute [Organization]
   793   C0086418:Human [Human]
   793   C0243107:development [Physiologic Function]
   793   C0678723:Development [Organism Function]
   793   C1272753:Institute [Idea or Concept]
   793   C1527148:Development [Functional Concept]
   793   C3245503:national [Intellectual Product]
   721 E C0458003:Developmental [Qualitative Concept]

Phrase: "National Institutes of Health,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "Bethesda,"

Phrase: "Maryland 20892"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024858:Maryland [Geographic Area]

Phrase: "Address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "all correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "requests for reprints"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C0686900:Request for [Functional Concept]
           request
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
   756   C3273171:Reprint [Intellectual Product]

Phrase: "to"

Phrase: ":"

Phrase: "Clara Cheng,"

Phrase: "Building"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1547706:Building [Functional Concept]
  1000   C1999269:Building [Manufactured Object]
   966 E C1707059:Build [Conceptual Entity]

Phrase: "10/CRC 1-3330,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0009402:CRC [Neoplastic Process]
   812   C1527249:CRC [Neoplastic Process]

Phrase: "10 Center Drive,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013126:Drive [Mental Process]

Phrase: "National Institutes of Health,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "Bethesda,"

Phrase: "Maryland 20892."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024858:Maryland [Geographic Area]
Processing 00000000.tx.4: E-mail: chengc{at}mail.nih.gov .  Abstract Top Abstract Introduction Materials and Methods Results Discussion References  IGF action has been implicated in the promotion of oxidative stress and aging in invertebrate and murine models. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "chengc{at}mail.nih.gov .  Abstract Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "IGF action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441472:Action [Functional Concept]
   861   C3266814:Action [Activity]

Phrase: "has"

Phrase: "been"

Phrase: "implicated in the promotion of oxidative stress"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   748   C0033414:Promotion [Activity]
   748   C0038435:Stress [Finding]
   748   C0311404:Oxidative [Functional Concept]

Phrase: "and"

Phrase: "aging in invertebrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001811:Ageing [Organism Function]

Phrase: "and"

Phrase: "murine models."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Models [Intellectual Product]
Processing 00000000.tx.5: However, some in vitro models suggest that IGF-I specifically prevents neuronal oxidative damage. 

Phrase: "However,"

Phrase: "some in vitro models"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C1515654:In Vitro Model [Research Activity]
   827   C3161035:Models [Intellectual Product]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that IGF-I specifically"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1334089:IGF I [Gene or Genome]
   827   C0021966:I- [Inorganic Chemical]
   827   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "neuronal oxidative damage."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0010957:Damage [Injury or Poisoning]
   827   C1883709:Damage [Functional Concept]
Processing 00000000.tx.6: To investigate whether IGF-I promotes or retards brain aging, we evaluated signs of oxidative stress and neuropathological aging in brains from 400-d-old Igf1/ and wild-type (WT) mice. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "IGF-I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:IGF I [Gene or Genome]
   861   C0021966:I- [Inorganic Chemical]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "or"

Phrase: "retards"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0521111:retard [Qualitative Concept]
   944 E C0311403:Inhibited [Qualitative Concept]
   944 E C3463820:Inhibiting [Activity]
   916 E C0018790:arrested [Disease or Syndrome]
   916 E C0237477:Arrest [Temporal Concept]
   916 E C0392351:arrest [Governmental or Regulatory Activity]

Phrase: "brain aging,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0001811:Ageing [Organism Function]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827 E C0001779:Age [Organism Attribute]

Phrase: "we"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "signs of oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0220912:signs [Functional Concept]
   770   C0220913:signs [Manufactured Object]
   770   C0311392:SIGNS [Finding]
   737 E C1547188:Sign [Idea or Concept]

Phrase: "and"

Phrase: "neuropathological aging in brains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0001811:Ageing [Organism Function]

Phrase: "from 400-"

Phrase: "d-"

Phrase: "old Igf1/"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0202220:IGF1 [Laboratory Procedure]
   861   C1334089:IGF I [Gene or Genome]
   861   C1708414:IGFI [Gene or Genome]

Phrase: "and"

Phrase: "wild-type (WT) mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.7: Lipofuscin pigment accumulation reflects oxidative stress and aging, but we found no difference in lipofuscin deposition in Igf1/ and WT brains. 

Phrase: "Lipofuscin pigment accumulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0333638:Lipofuscin accumulation [Pathologic Function]
   901   C1624584:pigment accumulation [Organism Function]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "aging,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "but"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no difference in lipofuscin deposition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "in Igf1/"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0202220:IGF1 [Laboratory Procedure]
  1000   C1334089:IGF I [Gene or Genome]
  1000   C1708414:IGFI [Gene or Genome]

Phrase: "and"

Phrase: "WT brains."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.8: Likewise, there was no apparent difference in accumulation of nitrotyrosine residues in Igf1/ and WT brains, except for layer IV/V of the cerebral cortex, where these proteins were about 20% higher in the Igf1/ brain (P = 0.03). 

Phrase: "Likewise,"

Phrase: "there"

Phrase: "was"

Phrase: "no apparent difference in accumulation of nitrotyrosine residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]

Phrase: "in Igf1/"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0202220:IGF1 [Laboratory Procedure]
  1000   C1334089:IGF I [Gene or Genome]
  1000   C1708414:IGFI [Gene or Genome]

Phrase: "and"

Phrase: "WT brains,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "except for layer IV/V"

Phrase: "of the cerebral cortex,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "where"

Phrase: "these proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "about 20% higher in the Igf1/ brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C0205250:High [Qualitative Concept]
   714   C1299351:High [Qualitative Concept]
   714   C2700149:HIGH [Intellectual Product]

Phrase: "(P = 0.03"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.9: We found no difference in the levels of oxidative stress-related enzymes, neuronal nitric oxide synthase, inducible nitric oxide synthase, and superoxide dismutase in Igf1/ and WT brains. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no difference in the levels of oxidative stress-related enzymes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1705241:*Difference [Quantitative Concept]
   739   C1705242:Difference [Qualitative Concept]

Phrase: "neuronal nitric oxide synthase,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0669368:Neuronal Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907533:Neuronal Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0030015:oxide [Inorganic Chemical]
   812   C0521390:Neuronal [Immunologic Factor]
   812   C2986642:oxide [Chemical Viewed Functionally]
   741 E C0027882:Neuron [Cell]

Phrase: "inducible nitric oxide synthase,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0669372:Nitric Oxide Synthase, Inducible [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417760:NITRIC OXIDE SYNTHASE, INDUCIBLE [Gene or Genome]
  1000   C1533698:Inducible Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "and"

Phrase: "superoxide dismutase in Igf1/"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0038838:Superoxide Dismutase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0038836:Superoxide [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "WT brains."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.10: Tau is a microtubule-associated protein that causes the formation of neurofibrillary tangles and senile plaques as it becomes hyperphosphorylated in the aging brain. 

Phrase: "Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "a microtubule-associated protein"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0026045:Microtubule-associated protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0026046:Micro-tubule [Cell Component]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332281:Associated [Qualitative Concept]
   793 E C0750490:Associate [Idea or Concept]
   793 E C1706221:Associate [Professional or Occupational Group]

Phrase: "that"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "the formation of neurofibrillary tangles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "as"

Phrase: "it"

Phrase: "becomes"

Phrase: "hyperphosphorylated in the aging brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0001811:Ageing [Organism Function]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.11: Tau phosphorylation was dramatically increased on two specific residues, Ser-396 and Ser-202, both glycogen synthase kinases target sites implicated in neurodegeneration. 

Phrase: "Tau phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "dramatically"

Phrase: "increased on two specific residues,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205217:Increased [Quantitative Concept]
   760   C0205369:Specific [Qualitative Concept]
   760   C0205448:Two [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1552740:specific [Intellectual Product]
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "Ser-396"

Phrase: "and"

Phrase: "Ser-202,"

Phrase: "both glycogen synthase kinases"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0206354:Glycogen Synthase Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   827   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "target"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "implicated in neurodegeneration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.12: These observations indicate that IGF-I has a major role in regulating tau phosphorylation in the aging brain, whereas its role in promoting or preventing oxidative stress remains uncertain.  

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "indicate"

Phrase: "that IGF-I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:IGF I [Gene or Genome]
   861   C0021966:I- [Inorganic Chemical]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "has"

Phrase: "a major role in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "regulating"

Phrase: "tau phosphorylation in the aging brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "whereas"

Phrase: "its role in promoting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "or"

Phrase: "preventing oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   827   C0311404:Oxidative [Functional Concept]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "remains"

Phrase: "uncertain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0087130:Uncertain [Idea or Concept]
Processing 00000000.tx.13: Introduction Top Abstract Introduction Materials and Methods Results Discussion References  RECENT STUDIES IN Caenorhabditis elegans and mice have implicated the insulin/IGF system in reduced longevity and oxidative stress resistance (1, 2). 

Phrase: "Introduction Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "RECENT STUDIES IN Caenorhabditis elegans"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "have"

Phrase: "implicated"

Phrase: "the insulin/IGF system in reduced longevity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0449913:System [Functional Concept]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]

Phrase: "and"

Phrase: "oxidative stress resistance"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0237834:Resistance [Mental Process]
   827   C1514892:Resistance [Physiologic Function]
   755 E C0332325:Resistant [Functional Concept]
   755 E C1550464:resistent [Idea or Concept]
   755 E C2827757:RESISTANT [Laboratory or Test Result]
   734   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.14: Reduced expression of insulin, IGF-I, or downstream signaling molecules extend the life span significantly (1, 3, 4, 5). 

Phrase: "Reduced expression of insulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "IGF-I,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:IGF I [Gene or Genome]
   861   C0021966:I- [Inorganic Chemical]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "or"

Phrase: "downstream signaling molecules"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C1519315:Signaling Molecule [Biologically Active Substance]
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "the life span significantly"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0870809:life span [Group Attribute]
   827   C0376558:Life [Idea or Concept]
   827   C1711300:Span [Conceptual Entity]
   827   C2700613:Span [Quantitative Concept]
   743 E C0595998:lives [Finding]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.15: Also, mice heterozygous for IGF-I receptor gene deletion display increased resistance to oxidative stress and increased lifespan (6). 

Phrase: "Also,"

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "heterozygous for IGF-I receptor gene deletion display increased resistance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0019425:Heterozygous [Organism Attribute]

Phrase: "to oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "increased lifespan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0870809:life span [Group Attribute]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.16: However, IGF-I appears to protect neurons from oxidative stress in vitro (7, 8, 9). 

Phrase: "However,"

Phrase: "IGF-I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:IGF I [Gene or Genome]
   861   C0021966:I- [Inorganic Chemical]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "protect"

Phrase: "neurons from oxidative stress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027882:Neurons [Cell]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(7,"

Phrase: "8,"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.17: In addition, reduction in circulating and brain IGF-I levels have been associated with aging and neurodegenerative conditions, and IGF-I has been suggested as a therapeutic agent in amyotrophic lateral sclerosis and Alzheimers disease (10, 11, 12). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "reduction in circulating"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0301630:Reduction [Natural Phenomenon or Process]
   790   C0392756:Reduction [Qualitative Concept]
   790   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "brain IGF-I levels"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441925:i levels [Intellectual Product]
   861   C1334089:IGF I [Gene or Genome]
   812   C0021966:I- [Inorganic Chemical]
   812   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "have"

Phrase: "been"

Phrase: "associated with aging"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0001811:Ageing [Organism Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "neurodegenerative conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "and"

Phrase: "IGF-I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:IGF I [Gene or Genome]
   861   C0021966:I- [Inorganic Chemical]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "has"

Phrase: "been"

Phrase: "suggested as a therapeutic agent"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0304231:Therapeutic agent [Intellectual Product]
   806   C1611640:Therapeutic agent [Pharmacologic Substance]
   760   C0039796:Therapeutic [Therapeutic or Preventive Procedure]
   760   C0302350:Therapeutic [Functional Concept]
   760   C0450442:Agent [Chemical Viewed Functionally]
   760   C1254351:Agent [Pharmacologic Substance]
   760   C1521826:Agent [Intellectual Product]
   726   C1705535:Suggest [Idea or Concept]

Phrase: "in amyotrophic lateral sclerosis"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0002736:Amyotrophic Lateral Sclerosis [Disease or Syndrome]
   901   C0154682:Lateral Sclerosis [Disease or Syndrome]
   827   C0036429:Sclerosis [Pathologic Function]
   827   C0205093:Lateral [Spatial Concept]
   755   C0026846:Amyotrophia [Disease or Syndrome]
   755 E C0334135:Sclerotic [Functional Concept]

Phrase: "and"

Phrase: "Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(10,"

Phrase: "11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.18: Thus, it has been suggested that increasing IGF-I may ameliorate the deterioration of brain aging and neurodegenerative disorders. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that increasing IGF-I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1334089:IGF I [Gene or Genome]
   827   C0021966:I- [Inorganic Chemical]
   827   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "may"

Phrase: "ameliorate"

Phrase: "the deterioration of brain aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0868945:Deterioration [Phenomenon or Process]

Phrase: "and"

Phrase: "neurodegenerative disorders."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
  1000   C1522560:Neurodegenerative Disorders [Functional Concept]
   861   C0012634:Disorders [Disease or Syndrome]
Processing 00000000.tx.19: In this study, we used IGF-I gene-targeted mice (Igf1/) to investigate whether IGF-I promotes or retards brain aging. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "IGF-I gene-targeted mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "(Igf1/"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0202220:IGF1 [Laboratory Procedure]
  1000   C1334089:IGF I [Gene or Genome]
  1000   C1708414:IGFI [Gene or Genome]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "IGF-I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:IGF I [Gene or Genome]
   861   C0021966:I- [Inorganic Chemical]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "or"

Phrase: "retards"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0521111:retard [Qualitative Concept]
   944 E C0311403:Inhibited [Qualitative Concept]
   944 E C3463820:Inhibiting [Activity]
   916 E C0018790:arrested [Disease or Syndrome]
   916 E C0237477:Arrest [Temporal Concept]
   916 E C0392351:arrest [Governmental or Regulatory Activity]

Phrase: "brain aging."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0001811:Ageing [Organism Function]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827 E C0001779:Age [Organism Attribute]
Processing 00000000.tx.20: Age-related neurodegenerative disorders such as Alzheimers and Parkinsons diseases are strongly correlated with oxidative stress. 

Phrase: "Age-related neurodegenerative disorders such as Alzheimers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
   778   C1522560:Neurodegenerative Disorders [Functional Concept]
   748   C0012634:Disorders [Disease or Syndrome]

Phrase: "and"

Phrase: "Parkinsons diseases"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   966   C0030567:Parkinson Disease [Disease or Syndrome]
   966   C1521736:Parkinson's Disease [Functional Concept]
   966   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]
   755   C1021144:Parkinsonia [Plant]

Phrase: "are"

Phrase: "strongly"

Phrase: "correlated with oxidative stress."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0038435:Stress [Finding]
   770   C0311404:Oxidative [Functional Concept]
   770   C1707520:Correlated [Qualitative Concept]
Processing 00000000.tx.21: Hence, we examined biomarkers of oxidative damage, such as lipofuscin and nitrotyrosine residues in aged Igf1/ and WT brains. 

Phrase: "Hence,"

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "biomarkers of oxidative damage,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0005516:Biomarkers [Clinical Attribute]

Phrase: "such as lipofuscin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023789:Lipofuscin [Biologically Active Substance,Lipid]

Phrase: "and"

Phrase: "nitrotyrosine residues in aged Igf1/"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "and"

Phrase: "WT brains."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.22: Lipofuscin consists of intracellular autofluorescent pigments that are deposited in neuronal soma and processes during the aging process (13). 

Phrase: "Lipofuscin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023789:Lipofuscin [Biologically Active Substance,Lipid]

Phrase: "consists of intracellular autofluorescent pigments"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031916:pigments [Chemical Viewed Functionally]
   760   C0175996:intracellular [Cell Component]
   760   C0178719:Intracellular [Spatial Concept]
   760   C0332529:CONSIST [Qualitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "deposited in neuronal soma"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   791   C2952302:Neuronal somata [Cell Component]
   770   C0333562:deposited [Functional Concept]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C0599444:soma [Cell Component]
   770   C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   715 E C0007248:Carisoprodol [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "processes during the aging process"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C1510835:Aging Process [Organism Function]
   726   C1184743:Process [Body Part, Organ, or Organ Component]
   726   C1522240:Process [Phenomenon or Process]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.23: The accumulation of nitrotyrosine residues is an indicator of the generation of reactive nitrogen species during aging progression. 

Phrase: "The accumulation of nitrotyrosine residues"

Phrase: "is"

Phrase: "an indicator of the generation of reactive nitrogen species"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0021212:indicator [Indicator, Reagent, or Diagnostic Aid]
   742   C1235732:Indicator [Bird]
   742   C1522602:Indicator [Functional Concept]

Phrase: "during aging progression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0242656:progression [Pathologic Function]
   861   C0449258:Progression [Functional Concept]
Processing 00000000.tx.24: We also examined enzymes that regulate oxidative activity, such as superoxide dismutase (SOD) and nitric oxide synthase (NOS). 

Phrase: "We also examined enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014442:Enzymes [Enzyme,Organic Chemical]
   827   C0014445:enzymes [Functional Concept]

Phrase: "that"

Phrase: "regulate"

Phrase: "oxidative activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "such as superoxide dismutase (SOD)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038838:Superoxide Dismutase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0038836:Superoxide [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "nitric oxide synthase (NOS)."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   901   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0030015:oxide [Inorganic Chemical]
   827   C2986642:oxide [Chemical Viewed Functionally]
Processing 00000000.tx.25: SOD catalyzes the conversion of superoxide radicals to H2O2, which is converted to H2O by peroxidase, protecting brain cells against oxidative stress (14). 

Phrase: "SOD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038838:Superoxide Dismutase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0038836:Superoxide [Element, Ion, or Isotope]

Phrase: "catalyzes"

Phrase: "the conversion of superoxide radicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439836:Conversion [Functional Concept]

Phrase: "to H2O2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "which"

Phrase: "is"

Phrase: "converted to H2O"

Phrase: "by peroxidase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "protecting"

Phrase: "brain cells against oxidative stress"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   806   C0596208:brain cells [Cell]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0007634:Cells [Cell]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.26: NOS, on the other hand, catalyzes synthesis of nitric oxide (NO), which then reacts with superoxide to form toxic peroxinitrite, causing cell damage during aging (15). 

Phrase: "NOS,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   901   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0030015:oxide [Inorganic Chemical]
   827   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "on the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "catalyzes"

Phrase: "synthesis of nitric oxide (NO),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   881   C1157570:nitric oxide synthesis [Molecular Function]
   770   C0220781:synthesis [Biologic Function]
   770   C1883254:Synthesis [Activity]

Phrase: "which then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "reacts with superoxide to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0038836:Superoxide [Element, Ion, or Isotope]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "toxic peroxinitrite,"

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "cell damage during aging"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0599732:cell damage [Cell or Molecular Dysfunction]
   819   C0007581:Cell Aging [Cell Function]
   819   C0178537:ageing cell [Temporal Concept]
   770   C0007634:Cell [Cell]
   770   C0010957:Damage [Injury or Poisoning]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1883709:Damage [Functional Concept]
   770   C1948049:Cell [Spatial Concept]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.27: In addition, brain aging is associated with increased phosphorylation of tau, a microtubule-associated protein involved in microtubule assembly and stabilization. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "brain aging"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0001811:Ageing [Organism Function]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827 E C0001779:Age [Organism Attribute]

Phrase: "is"

Phrase: "associated with increased phosphorylation of tau,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0031715:Phosphorylation [Molecular Function]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C1158886:Phosphorylation [Molecular Function]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "a microtubule-associated protein"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0026045:Microtubule-associated protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0026046:Micro-tubule [Cell Component]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332281:Associated [Qualitative Concept]
   793 E C0750490:Associate [Idea or Concept]
   793 E C1706221:Associate [Professional or Occupational Group]

Phrase: "involved in microtubule assembly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0026046:Micro-tubule [Cell Component]
   770   C1314939:Involved [Functional Concept]
   770   C1706853:Assembly [Activity]
   770   C1879748:Assembly [Manufactured Object]

Phrase: "and"

Phrase: "stabilization."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1293130:Stabilisation [Therapeutic or Preventive Procedure]
Processing 00000000.tx.28: Tau hyperphosphorylation is believed to lead to its disengagement from microtubule, destabilizing microtubule and disrupting normal microtubule-dependent processes (16). 

Phrase: "Tau hyperphosphorylation"

Phrase: "is"

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "lead to its disengagement"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "from microtubule,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Micro-tubule [Cell Component]

Phrase: "destabilizing microtubule"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026046:Micro-tubule [Cell Component]

Phrase: "and"

Phrase: "disrupting normal microtubule-dependent processes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   836   C0544955:Microtubule Process [Cell or Molecular Dysfunction]
   771   C1184743:Process [Body Part, Organ, or Organ Component]
   771   C1522240:Process [Phenomenon or Process]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.29: The unbound tau is thought to be more resistant to degradation and more prone to aggregation, culminating in the formation of neurofibrillary tangles (NFTs) (16, 17). 

Phrase: "The unbound tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "more resistant to degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332325:Resistant to [Functional Concept]
           Resistant
   770   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "and"

Phrase: "more prone to aggregation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033422:Prone [Spatial Concept]

Phrase: "culminating in the formation of neurofibrillary tangles (NFTs)"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   778   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   748   C0205260:Culminating [Qualitative Concept]
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]
   745 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "(16,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.30: Hyperphosphorylated, insoluble tau in the form of NFTs is associated with cognitive dysfunction in normal aging as well as a variety of late onset neurodegenerative disorders termed "tauopathies" (16, 18). 

Phrase: "Hyperphosphorylated"

Phrase: ","

Phrase: "insoluble tau in the form of NFTs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1720655:Tau [Intellectual Product]
   744   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "associated with cognitive dysfunction"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C0338656:Cognitive dysfunction [Mental or Behavioral Dysfunction]
   770   C0031847:dysfunction [Functional Concept]
   770   C0277785:Dysfunction, NOS [Qualitative Concept]
   770   C1516691:Cognitive [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C0231174:Malfunction [Functional Concept]
   715 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "in normal aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001811:Ageing [Organism Function]

Phrase: "as well as"

Phrase: "a variety of late onset neurodegenerative disorders"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1883525:Variety [Conceptual Entity]
   748   C2346866:Variety [Conceptual Entity]

Phrase: "termed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1515273:Term [Temporal Concept]
   966   C1705313:Term [Idea or Concept]
   966   C2826302:TERM [Intellectual Product]

Phrase: """tauopathies"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949664:Tauopathies [Disease or Syndrome]

Phrase: "(16,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.31: We therefore evaluated tau protein levels and phosphorylation status in the aged Igf1/ and WT control brains to elucidate IGF-Is role in regulation of this important neuropathological factor.  

Phrase: "We therefore evaluated tau protein levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   806   C0428479:Protein level [Laboratory or Test Result]
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "phosphorylation status in the aged Igf1/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449438:Status [Qualitative Concept]

Phrase: "and"

Phrase: "WT control brains to"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   804   C0006104:Brains [Body Part, Organ, or Organ Component]
   804   C0243148:control [Qualitative Concept]
   804   C1550141:Control [Substance]
   804   C1882979:Control [Conceptual Entity]
   804   C2587213:Control [Functional Concept]
   804   C3274648:Control [Qualitative Concept]
   771 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "elucidate"

Phrase: "IGF-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]

Phrase: "Is"

Phrase: "role in regulation of this important neuropathological factor."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.32: Materials and Methods Top Abstract Introduction Materials and Methods Results Discussion References  Animals The mice used in this study were from an Igf1 deletion line derived and genotyped as previously described (19). 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "The mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "were from an Igf1 deletion line"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0202220:IGF1 [Laboratory Procedure]
   753   C0205132:Line [Spatial Concept]
   753   C1334089:IGF I [Gene or Genome]
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1550648:Line [Substance]
   753   C1552960:Line [Quantitative Concept]
   753   C1708414:IGFI [Gene or Genome]
   753   C1880274:Deletion [Activity]

Phrase: "derived"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441547:Derived [Qualitative Concept]
  1000   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.33: Animals were studied under protocols approved by the NICHD Animal Use and Care Committee. 

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "studied under protocols"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   824   C1507394:Study Protocol [Intellectual Product]
       E   Protocol
   824   C2348563:Study Protocol [Intellectual Product]
       E   Protocol
   790   C0442711:Protocols [Intellectual Product]
   756   C0557651:Study [Manufactured Object]
   756 E C1522729:Protocol [Intellectual Product]
   756   C2603343:Study [Research Activity]

Phrase: "approved by the NICHD Animal Use"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0003062:Animal [Animal]
   753   C0042153:use [Functional Concept]
   753   C0205540:Approved [Qualitative Concept]
   753   C0457083:Use [Functional Concept]
   753   C1513896:NICHD [Health Care Related Organization]
   753   C1947944:Use [Intellectual Product]
   753   C2982885:NICHD [Intellectual Product]

Phrase: "and"

Phrase: "Care Committee."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2699414:Committee [Group]
Processing 00000000.tx.34: Male Igf1/ mice and age-sex-matched littermates were euthanized at postnatal d 400 in CO2 chamber followed by decapitation. 

Phrase: "Male Igf1/ mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "age-sex-matched littermates"

Phrase: "were"

Phrase: "euthanized at postnatal d 400"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0443281:Postnatal [Temporal Concept]

Phrase: "in CO2 chamber"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "followed by decapitation."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0152232:Decapitation [Injury or Poisoning]
   790   C0413398:Decapitation [Injury or Poisoning]
   756 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.35: Brains were rapidly dissected, cut along the sagittal midline, and snap frozen. 

Phrase: "Brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "dissected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205239:dissected [Functional Concept]

Phrase: ","

Phrase: "cut along the sagittal midline,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0000925:Cut [Injury or Poisoning]
   760   C1883724:CUT [Phenomenon or Process]

Phrase: "and"

Phrase: "snap"

Phrase: "frozen."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016701:Frozen [Natural Phenomenon or Process]
  1000   C0677542:Frozen [Functional Concept]
Processing 00000000.tx.36: One brain half was used for protein preparation, and the other half was sectioned for histochemistry. 

Phrase: "One brain half"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2825407:Half [Quantitative Concept]

Phrase: "was"

Phrase: "used for protein preparation,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0455052:Preparation [Health Care Activity]
   770   C1273517:used [Finding]
   770   C1521827:Preparation [Functional Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "the other half"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825407:Half [Quantitative Concept]

Phrase: "was"

Phrase: "sectioned for histochemistry."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0019635:Histochemistry [Laboratory Procedure]
   756   C0205155:Section [Spatial Concept]
   756   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   756   C1522472:Section [Substance]
   756   C1552923:Section [Quantitative Concept]
   756   C1705191:Section [Physical Object]
Processing 00000000.tx.37: Sections 10-m thick were cut sagittally at 20 C, thaw-mounted onto poly-L-lysine-coated slides, and stored at 70 C until use. 

Phrase: "Sections 10-m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "thick"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1280412:Thick [Qualitative Concept]

Phrase: "were"

Phrase: "cut"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0000925:Cut [Injury or Poisoning]
  1000   C1883724:CUT [Phenomenon or Process]

Phrase: "sagittally at 20 C,"

Phrase: "thaw-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710378:Thaw [Laboratory Procedure]

Phrase: "mounted onto poly-L-lysine-coated slides,"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   748   C0024337:Lysine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0444330:slides [Research Device]
   748   C0449878:mounted [Finding]
   748   C0747726:POLY [Conceptual Entity]
   748   C1522408:Coated [Qualitative Concept]
   714 E C0181909:Mount [Medical Device]
   714 E C0453946:Coat [Manufactured Object]
   714 E C1705201:Slide [Manufactured Object]
   714 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "stored at 70 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1698986:Store [Functional Concept]

Phrase: "until use."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]
Processing 00000000.tx.38: Lipofuscin detection Frozen sections were thawed and directly mounted with DAPI media (Vector Laboratories, Burlingame, CA). 

Phrase: "Lipofuscin detection Frozen sections"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   861   C0016741:Frozen Sections [Tissue]
   827 E C0085188:Frozen Section [Laboratory Procedure]
   812   C0016701:Frozen [Natural Phenomenon or Process]
   812   C0677542:Frozen [Functional Concept]
   779   C0205155:Section [Spatial Concept]
   779   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   779   C1522472:Section [Substance]
   779   C1552923:Section [Quantitative Concept]
   779   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "thawed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710378:Thaw [Laboratory Procedure]

Phrase: "and"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "mounted with DAPI media"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0009458:Media [Intellectual Product]
   770   C0057142:DAPI [Organic Chemical,Pharmacologic Substance]
   770   C0162867:Media [Tissue]
   770   C0449878:mounted [Finding]
   770   C1254021:Media [Tissue]
   737 E C0181909:Mount [Medical Device]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]

Phrase: "(Vector Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: "Burlingame,"

Phrase: "CA)."
Processing 00000000.tx.39: The sections were then examined directly under fluorescent microscope. 

Phrase: "The sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "directly under fluorescent microscope."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0181839:Microscope [Medical Device]
   770   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C1706379:Microscope [Medical Device]
   770   C1947931:Directly [Qualitative Concept]
Processing 00000000.tx.40: The intracellular autofluorescent pigments known as lipofuscin gave a bright yellow fluorescent signal, whereas DAPI-stained nuclei gave a blue fluorescent signal. 

Phrase: "The intracellular autofluorescent pigments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0031916:pigments [Chemical Viewed Functionally]
   743 E C0333610:Pigmented [Qualitative Concept]

Phrase: "known as lipofuscin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0023789:Lipofuscin [Biologically Active Substance,Lipid]
   790   C0205309:Known [Qualitative Concept]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "a bright yellow fluorescent signal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1710082:Signal [Phenomenon or Process]

Phrase: "whereas"

Phrase: "DAPI-stained nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0007610:Nucleus [Cell Component]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "a blue fluorescent signal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.41: For the Sudan Black B staining, frozen sections were first fixed in 4% formaldehyde for 5 min, rinsed in water, and immersed in Sudan Black B reagent (Sigma Diagnostics, St. Louis, MO) overnight. 

Phrase: "For the Sudan Black B staining,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0487602:Staining [Laboratory Procedure]
   812   C1704680:Staining [Finding]
   756   C0075489:Sudan Black B [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "frozen sections"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0016741:Frozen Sections [Tissue]
   966 E C0085188:Frozen Section [Laboratory Procedure]
   861   C0016701:Frozen [Natural Phenomenon or Process]
   861   C0677542:Frozen [Functional Concept]
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "fixed in 4% formaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "for 5 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "rinsed in water,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   790   C0599638:WATER [Substance]
   790   C1550678:Water [Inorganic Chemical]
   756   C1701810:Rinse [Functional Concept]
   756   C1882955:Rinse [Activity]
   718 E C0443350:Watery [Qualitative Concept]

Phrase: "and"

Phrase: "immersed in Sudan Black B reagent"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0075489:Sudan Black B [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0005680:Black [Population Group]
   753   C0027567:Black [Population Group]
   753   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   753   C0038642:Sudan [Geographic Area]
   753   C0085756:Black [Population Group]
   753   C0439541:Black [Qualitative Concept]

Phrase: "(Sigma Diagnostics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011900:Diagnostic [Finding]
   827   C0348026:Diagnostic [Functional Concept]

Phrase: "St. Louis,"

Phrase: "MO) overnight."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439583:Overnight [Temporal Concept]
   861   C3538743:MO [Idea or Concept]
Processing 00000000.tx.42: After quick differentiation in 70% EtOH, the slides were washed in 50, 30% EtOH, water and then counterstained in Nuclear fast red (Sigma Diagnostics) for 3 min. 

Phrase: "After quick differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "in 70% EtOH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001962:ETOH [Organic Chemical]

Phrase: "the slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0444330:slides [Research Device]
   966 E C1705201:Slide [Manufactured Object]

Phrase: "were"

Phrase: "washed in 50,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1548982:Washed [Idea or Concept]
   756 E C0441648:Wash [Activity]

Phrase: "30% EtOH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001962:ETOH [Organic Chemical]

Phrase: "water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "counterstained in Nuclear fast red (Sigma Diagnostics"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0303913:nuclear fast red [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0015663:Fast [Finding]
   748   C0332575:Red [Finding]
   748   C0456962:Fast [Qualitative Concept]
   748   C0521447:Nuclear [Spatial Concept]
   748   C1260956:Red [Qualitative Concept]
   748   C1719918:Sigma [Intellectual Product]
   714   C0011900:Diagnostic [Finding]
   714   C0348026:Diagnostic [Functional Concept]

Phrase: ")"

Phrase: "for 3 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.43: Immunohistochemistry Immunohistochemistry was performed by the avidin-biotin-immunoperoxidase method (20). 

Phrase: "Immunohistochemistry Immunohistochemistry"

Phrase: "was"

Phrase: "performed by the avidin-biotin-immunoperoxidase method"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   778   C1550369:Performed By [Qualitative Concept]
   748   C0004434:Avidin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0005575:Biotin [Organic Chemical,Pharmacologic Substance,Vitamin]
   748   C0021067:Immunoperoxidase [Laboratory Procedure]
   748   C0025663:Method [Intellectual Product]
   748   C0449851:Method [Functional Concept]
   748   C0871511:METHOD [Intellectual Product]
   748   C0884358:Performed [Functional Concept]
   748   C2700256:Biotin [Laboratory Procedure]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.44: Briefly, frozen sections were fixed in 4% formaldehyde for 10 min then washed in 1x Tris/NaCl buffer [50 mM Tris/150 mM NaCl/0.1% Triton (pH 7.5)]. 

Phrase: "Briefly,"

Phrase: "frozen sections"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0016741:Frozen Sections [Tissue]
   966 E C0085188:Frozen Section [Laboratory Procedure]
   861   C0016701:Frozen [Natural Phenomenon or Process]
   861   C0677542:Frozen [Functional Concept]
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "fixed in 4% formaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "for 10 min then"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0456692:/10 min [Temporal Concept]
   827   C0702093:/min [Temporal Concept]

Phrase: "washed in 1x Tris/NaCl buffer"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   783   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   753   C0814229:TRI [Intellectual Product]
   753   C1548982:Washed [Idea or Concept]
   753   C1959973:% NaCl [Quantitative Concept]
   719 E C0441648:Wash [Activity]

Phrase: "[50 mM Tris/150 mM NaCl/0.1% Triton"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0242759:Triton [Geographic Area]
   700   C1418486:MM-1 [Gene or Genome]

Phrase: "(pH 7.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "]."
Processing 00000000.tx.45: To remove endogenous peroxidase activity, slides were placed in 3% H2O2 solution for 10 min and then washed in the Tris/NaCl buffer. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "endogenous peroxidase activity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1151518:peroxidase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0444330:slides [Research Device]
   966 E C1705201:Slide [Manufactured Object]

Phrase: "were"

Phrase: "placed in 3% H2O2 solution"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0037633:Solution [Substance]
   760   C0525069:Solution [Biomedical or Dental Material]
   726   C0442504:Place [Spatial Concept]
   726   C1704765:Place [Functional Concept]
   726   C1882509:Place [Activity]
   726   C3496241:place [Disease or Syndrome]

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed in the Tris/NaCl buffer."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   783   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   753   C0814229:TRI [Intellectual Product]
   753   C1548982:Washed [Idea or Concept]
   753   C1959973:% NaCl [Quantitative Concept]
   719 E C0441648:Wash [Activity]
Processing 00000000.tx.46: Nonspecific signal was blocked by incubating slides with 10% normal goat serum in blocking solution [1% BSA/0.02% Na-Azide/0.05% Triton X-100 in Tris/NaCl buffer (pH 7.5)] for 45 min. 

Phrase: "Nonspecific signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "blocked by incubating slides"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0028778:Blocked [Pathologic Function]
   770   C0332206:Blocked [Functional Concept]
   770   C0444330:slides [Research Device]
   770   C1439852:incubating [Laboratory Procedure]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1705201:Slide [Manufactured Object]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "with 10% normal goat serum"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   812   C0018019:goat [Mammal]
   812   C0205307:Normal [Qualitative Concept]
   812   C0229671:Serum [Body Substance]
   812   C0439166:% normal [Quantitative Concept]
   812   C1265549:goat [Mammal]
   812   C1510458:Goat [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   812   C2347086:% Normal [Quantitative Concept]

Phrase: "in blocking solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "[1% BSA/0.02% Na-Azide/0.05% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   816   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   801   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   788   C0242759:Triton [Geographic Area]

Phrase: "in Tris/NaCl buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(pH 7.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "]"

Phrase: "for 45 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.47: The sections were then incubated at 4 C with antinitrotyrosine antibody (1:500; 

Phrase: "The sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated at 4 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "with antinitrotyrosine antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500"

Phrase: ";"
Processing 00000000.tx.48: Chemicon, Temecula, CA) overnight. 

Phrase: "Chemicon,"

Phrase: "Temecula,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555271:Temecula [Population Group]

Phrase: "CA) overnight."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439583:Overnight [Temporal Concept]
Processing 00000000.tx.49: After washing, the sections were incubated with biotinylated secondary antibodies (1:400; 

Phrase: "After washing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "the sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "incubated with biotinylated secondary antibodies"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0027627:secondary [Neoplastic Process]
   760   C0175668:Secondary [Temporal Concept]
   760   C0205436:Secondary [Quantitative Concept]
   760   C1439852:Incubated [Laboratory Procedure]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "400"

Phrase: ";"
Processing 00000000.tx.50: New England Biolabs, Beverly, MA) at room temperature for 40 min. 

Phrase: "New England Biolabs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027965:New England [Geographic Area]

Phrase: "Beverly,"

Phrase: "MA) at room temperature"

Phrase: "for 40 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.51: The signal was amplified using the ABC peroxidase method (Vector Laboratories) and visualized with 3,3'-diaminibenzidine (Vector Laboratories). 

Phrase: "The signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "amplified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the ABC peroxidase method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]

Phrase: "(Vector Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "visualized with 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0234621:Visualized [Functional Concept]

Phrase: "3'-diaminibenzidine"

Phrase: "(Vector Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: ")."
Processing 00000000.tx.52: The semiquantitation of nitrotyrosine immunosignals was carried out in a blinded fashion. 

Phrase: "The semiquantitation of nitrotyrosine immunosignals"

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in a blinded fashion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0150108:Blinded [Research Activity]
   760   C0439787:Out [Spatial Concept]
   760   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.53: The signals were captured at x200 using a video camera and analyzed using NIH image software (Image 1.57, NIH) in several brain structures, including frontal cortex layer II/III, layer VI/V, thalamus (ventrolateral thalamic nuclei and ventramedial thalamic nuclei), hypothalamus (lateral hypothalamus area) and striatum (accumbens nuclei). 

Phrase: "The signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "captured at x200"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a video camera"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0179547:video camera [Medical Device]
   861   C0042655:Video [Manufactured Object]
   861   C0179533:Camera [Medical Device]
   861   C1654607:Camera [Eukaryote]
   861   C1706254:CAMERA [Medical Device]
   861   C3463807:Video [Intellectual Product]

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "NIH image software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Image 1.57,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "NIH) in several brain structures,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0027468:NIH [Health Care Related Organization]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "frontal cortex layer II/III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0439070:III [Intellectual Product]
   804   C1705160:III [Qualitative Concept]

Phrase: "layer VI/V,"

Phrase: "thalamus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039729:Thalamus [Body Part, Organ, or Organ Component]
  1000   C1269896:Thalamus [Body Part, Organ, or Organ Component]

Phrase: "(ventrolateral thalamic nuclei"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   988   C0228339:Ventrolateral Thalamic Nucleus [Body Part, Organ, or Organ Component]
   901   C0039727:Thalamic Nuclei [Body Part, Organ, or Organ Component]
   793   C0007610:Nucleus [Cell Component]

Phrase: "and"

Phrase: "ventramedial thalamic nuclei"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0039727:Thalamic Nuclei [Body Part, Organ, or Organ Component]
   793   C0007610:Nucleus [Cell Component]

Phrase: ")"

Phrase: ","

Phrase: "hypothalamus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020663:Hypothalamus [Body Part, Organ, or Organ Component]
  1000   C1280712:Hypothalamus [Body Part, Organ, or Organ Component]

Phrase: "(lateral hypothalamus area"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017446:Area [Geographic Area]
   827   C0205146:Area [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "striatum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010097:Striatum [Body Part, Organ, or Organ Component]
  1000   C0162512:Striatum [Body Part, Organ, or Organ Component]

Phrase: "(accumbens nuclei"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0028633:Accumbens nucleus [Body Part, Organ, or Organ Component]
   827   C0007610:Nucleus [Cell Component]

Phrase: ")."
Processing 00000000.tx.54: Background signal from each slide was subtracted before further analysis. 

Phrase: "Background signal from each slide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "subtracted before further analysis."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1517331:Further [Spatial Concept]
   770   C1524024:analysis [Functional Concept]
   737 E C0205108:far [Spatial Concept]
   737   C1719767:Subtract [Intellectual Product]
   737   C2348589:Subtract [Phenomenon or Process]
Processing 00000000.tx.55: Two sections from each brain were scored and n = 4 and 5 for Igf1/ and WT controls, respectively. 

Phrase: "Two sections from each brain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   726   C0205155:Section [Spatial Concept]
   726   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   726   C1522472:Section [Substance]
   726   C1552923:Section [Quantitative Concept]
   726   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "scored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449820:scored [Quantitative Concept]

Phrase: "and"

Phrase: "n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "5 for Igf1/"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0202220:IGF1 [Laboratory Procedure]
   790   C0439084:>5 [Quantitative Concept]
   790   C0728893:+5 [Quantitative Concept]
   790   C1334089:IGF I [Gene or Genome]
   790   C1708414:IGFI [Gene or Genome]

Phrase: "and"

Phrase: "WT controls,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   793   C0243148:control [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "respectively."
Processing 00000000.tx.56: Differences between groups were compared by ANOVA followed by Fishers least significant different tests. 

Phrase: "Differences between groups"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "compared by ANOVA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "followed by Fishers least significant different tests."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0022885:Tests [Laboratory Procedure]
   748   C0237881:significant [Quantitative Concept]
   748   C0392366:Tests [Intellectual Product]
   748   C0750502:Significant [Idea or Concept]
   748   C1546944:Significant [Qualitative Concept]
   748   C1705242:Different [Qualitative Concept]
   741   C1708064:Fisher's Test [Intellectual Product]
   714 E C0039593:Test [Functional Concept]
   714   C0325045:Fisher [Mammal]
   714 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.57: Immunoblotting Immunoblotting was performed according to Cheng et al. 

Phrase: "Immunoblotting Immunoblotting"

Phrase: "was"

Phrase: "performed according to Cheng et al."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0680240:according [Social Behavior]
   753   C0884358:Performed [Functional Concept]
   719 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.58: (21). 

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.59: Mouse brains (0.4 g) were homogenized in a boiling solution containing 10 mM Tris (pH 7.4), 1 mM sodium orthovanadate, and 1% sodium dodecyl sulfate at a ratio of 1 g tissue to 17.5 ml solution. 

Phrase: "Mouse brains"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1521713:Mouse Brain [Tissue]
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(0.4 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "homogenized in a boiling solution"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0037633:Solution [Substance]
   760   C0525069:Solution [Biomedical or Dental Material]
   726   C0242301:Boil [Disease or Syndrome]
   726   C1546559:Boil [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10 mM Tris"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "1 mM sodium orthovanadate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0029366:Orthovanadate [Inorganic Chemical]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "1% sodium dodecyl sulfate at a ratio of 1 g tissue"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   775   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   756   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   754   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   754   C0597484:Sodium 1+ [Element, Ion, or Isotope,Pharmacologic Substance]
           Sodium+
   738   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   738   C0038720:Sulfate [Inorganic Chemical]
   738   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   738   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "to 17.5 ml solution."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037633:Solution [Substance]
   812   C0525069:Solution [Biomedical or Dental Material]
Processing 00000000.tx.60: Ten microliters of each sample were loaded and resolved on NuPAGE 10% Bis-Tris Gels (Invitrogen Life Technologies, Carlsbad, CA) and transferred to nitrocellulose membranes using electrophoretic transfer cells (Bio-Rad, Hercules, CA). 

Phrase: "Ten microliters of each sample"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439243:microliter [Quantitative Concept]

Phrase: "were"

Phrase: "loaded"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708715:Loaded [Activity]
   966 E C1550025:Load [Idea or Concept]
   966 E C1704782:Load [Manufactured Object]

Phrase: "and"

Phrase: "resolved on NuPAGE 10% Bis-Tris Gels"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C0053809:Bis-Tris [Organic Chemical]
   748   C0017243:Gels [Biomedical or Dental Material]
   748   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   748   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   748   C0556985:BIS [Temporal Concept]
   748   C0814229:TRI [Intellectual Product]
   748   C1514893:Resolved [Idea or Concept]
   748   C2247301:BIS [Molecular Function]
   748   C2699488:Resolved [Conceptual Entity]
   748   C3540495:BIS [Intellectual Product]
   714 E C1382104:Gel [Substance]

Phrase: "(Invitrogen Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0039421:technologies [Occupation or Discipline]

Phrase: "Carlsbad,"

Phrase: "CA)"

Phrase: "and"

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0025255:Membranes [Tissue]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "electrophoretic transfer cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(Bio-Rad,"

Phrase: "Hercules,"

Phrase: "CA)."
Processing 00000000.tx.61: To ensure equal loading and transfer efficiency, the membranes were prestained with Ponceau S solution (Sigma) before immunodetection. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "equal loading"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708715:Loading [Activity]

Phrase: "and"

Phrase: "transfer efficiency,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013682:Efficiency [Quantitative Concept]
   789 E C0442799:Efficient [Qualitative Concept]

Phrase: "the membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "prestained with Ponceau S solution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0071720:Ponceau S [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0037633:Solution [Substance]
   760   C0525069:Solution [Biomedical or Dental Material]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "before"

Phrase: "immunodetection."
Processing 00000000.tx.62: Primary antibodies were purchased and diluted to use as follows: antiphospho-tau-396 (1:500; 

Phrase: "Primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "purchased"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0869011:purchased [Activity]

Phrase: "and"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "antiphospho-tau-396"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500"

Phrase: ";"
Processing 00000000.tx.63: Zymed Laboratories, South San Francisco, CA), neuronal NOS (nNOS) and inducible NOS (iNOS) (1:1000; 

Phrase: "Zymed Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: "South San Francisco,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036152:San Francisco [Geographic Area]
   827   C1826357:San [Gene or Genome]

Phrase: "CA),"

Phrase: "neuronal NOS (NOS)"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0669368:Neuronal Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907533:Neuronal Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0030015:oxide [Inorganic Chemical]
   812   C0521390:Neuronal [Immunologic Factor]
   812   C2986642:oxide [Chemical Viewed Functionally]
   741 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "inducible NOS (NOS)"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0669372:Nitric Oxide Synthase, Inducible [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417760:NITRIC OXIDE SYNTHASE, INDUCIBLE [Gene or Genome]
  1000   C1533698:Inducible Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: ";"
Processing 00000000.tx.64: Chemicon International, Temecula, CA), SOD1 (1:500; 

Phrase: "Chemicon International, Temecula,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1555271:Temecula [Population Group]

Phrase: "CA),"

Phrase: "SOD1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1151619:SOD-1 [Molecular Function]
  1000   C1420306:SOD1 [Gene or Genome]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500"

Phrase: ";"
Processing 00000000.tx.65: Chemicon), tau-1 (1:500; 

Phrase: "Chemicon"

Phrase: ")"

Phrase: ","

Phrase: "tau-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0250875:tau-1 [Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500"

Phrase: ";"
Processing 00000000.tx.66: Chemicon), AT-8 (1:100; 

Phrase: "Chemicon"

Phrase: ")"

Phrase: ","

Phrase: "AT-8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516077:At [Spatial Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "100"

Phrase: ";"
Processing 00000000.tx.67: Pierce Endogen, Rockford, IL), 12E8 (1:5000; 

Phrase: "Pierce Endogen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   768   C0205227:Endogenous [Functional Concept]

Phrase: "Rockford,"

Phrase: "IL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "12E8"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "5000"

Phrase: ";"
Processing 00000000.tx.68: provided by Dr. 

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.69: Peter Seubert at Elan Pharmaceuticals, Inc., San Francisco, CA) and tau-5 (1:500; 

Phrase: "Peter Seubert at Elan Pharmaceuticals,"

Phrase: "Inc.,"

Phrase: "San Francisco,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036152:San Francisco [Geographic Area]
   861   C1826357:San [Gene or Genome]

Phrase: "CA)"

Phrase: "and"

Phrase: "tau-5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500"

Phrase: ";"
Processing 00000000.tx.70: Biosource International Inc., Camarillo, CA). 

Phrase: "Biosource International Inc.,"

Phrase: "Camarillo,"

Phrase: "CA)."
Processing 00000000.tx.71: After incubation with primary antibodies for 90 min and washed, the membranes were incubated with horseradish peroxidase-linked secondary antibodies for 60 min. 

Phrase: "After incubation"

Phrase: "with primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "for 90 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "washed,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "the membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "incubated with horseradish peroxidase-linked secondary antibodies"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   778   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0027627:secondary [Neoplastic Process]
   748   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0175668:Secondary [Temporal Concept]
   748   C0205436:Secondary [Quantitative Concept]
   748   C0330510:Horseradish [Food]
   748   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   748   C1110641:Horseradish [Plant]
   748   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   748   C1439852:Incubated [Laboratory Procedure]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]

Phrase: "for 60 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.72: Protein bands were then visualized using SuperSignal West Pico detection reagents (Pierce, Rockford, IL) on a Kodak image machine (Kodak, Rochester, NY). 

Phrase: "Protein bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "SuperSignal West Pico detection reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Pierce,"

Phrase: "Rockford,"

Phrase: "IL) on a Kodak image machine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0020898:IL [Geographic Area]
   753   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0022271:IL [Geographic Area]

Phrase: "(Kodak,"

Phrase: "Rochester,"

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.73: Digital image of the results from each blot was obtained, and the intensity of protein bands revealed by each specific antibody was compared and analyzed using Kodak 1D image-analysis software. 

Phrase: "Digital image of the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1704254:Image [Intellectual Product]
   760   C1704922:Image [Entity]
   760   C3542466:Image [Intellectual Product]

Phrase: "from each blot"

Phrase: "was"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: ","

Phrase: "and"

Phrase: "the intensity of protein bands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0522510:Intensity [Qualitative Concept]

Phrase: "revealed by each specific antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0205369:Specific [Qualitative Concept]
   760   C0443289:Revealed [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]

Phrase: "was"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Kodak 1D image-analysis software."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.74: Differences between groups were compared by ANOVA followed by Fishers least significant different tests (n = 34 for Igf1/ brains and n = 5 for WT controls). 

Phrase: "Differences between groups"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "compared by ANOVA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "followed by Fishers least significant different tests"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0022885:Tests [Laboratory Procedure]
   748   C0237881:significant [Quantitative Concept]
   748   C0392366:Tests [Intellectual Product]
   748   C0750502:Significant [Idea or Concept]
   748   C1546944:Significant [Qualitative Concept]
   748   C1705242:Different [Qualitative Concept]
   741   C1708064:Fisher's Test [Intellectual Product]
   714 E C0039593:Test [Functional Concept]
   714   C0325045:Fisher [Mammal]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "(n = 34 for Igf1/ brains"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0006104:Brains [Body Part, Organ, or Organ Component]
   760   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0202220:IGF1 [Laboratory Procedure]
   760   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441922:N+ [Intellectual Product]
   760   C1334089:IGF I [Gene or Genome]
   760   C1553036:[n] [Quantitative Concept]
   760   C1708414:IGFI [Gene or Genome]
   726 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "n = 5 for WT controls"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   790   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   790   C1883559:Wild Type [Organism Attribute]
   783   C0457499:Type 5 [Intellectual Product]
   767   C1707504:Control Type [Research Activity]
   767   C1879930:Control Type [Intellectual Product]
   753   C0332307:Type [Qualitative Concept]
   753   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441922:N+ [Intellectual Product]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
   753   C1553036:[n] [Quantitative Concept]
   719   C0243148:control [Qualitative Concept]
   719   C1550141:Control [Substance]
   719   C1882979:Control [Conceptual Entity]
   719   C2587213:Control [Functional Concept]
   719   C3274648:Control [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.75: All the immunoblottings were repeated at least once, and the data were confirmed. 

Phrase: "All"

Phrase: "the immunoblottings"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblottings [Laboratory Procedure]

Phrase: "were"

Phrase: "repeated at least"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0205341:Repeated [Functional Concept]
   756 E C1547730:Repeat [Temporal Concept]
   756 E C1705914:Repeat [Conceptual Entity]

Phrase: "once"

Phrase: ","

Phrase: "and"

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "confirmed."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.76: In situ hybridization The tau clone (Image clone ID no. 746947, ATCC no. 1015357) was obtained from American Type Culture Collection (ATCC, Manassas, VA). 

Phrase: "In situ hybridization"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   901   C0444498:In situ [Spatial Concept]
   827   C0020202:Hybridisation [Genetic Function]
   827   C1300517:Hybridization [Laboratory Procedure]

Phrase: "The tau clone"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0009013:Clone [Cell]
   861   C1522642:Clone [Tissue]
   789 E C1704387:Clonal [Qualitative Concept]
   761 E C0796368:clonality [Diagnostic Procedure]

Phrase: "(Image clone ID"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C3261218:Image ID [Intellectual Product]
   827   C0600091:ID [Intellectual Product]

Phrase: "no. 746947,"

Phrase: "ATCC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598079:ATCC [Intellectual Product]

Phrase: "no. 1015357"

Phrase: ")"

Phrase: "was"

Phrase: "obtained from American Type Culture Collection"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   882   C0598079:American Type Culture Collection [Intellectual Product]
   753   C0010453:Culture [Idea or Concept]
   753   C0220814:culture [Functional Concept]
   753   C0332307:Type [Qualitative Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C0596070:American [Population Group]
   753   C1301820:Obtained [Functional Concept]
   753   C1516698:Collection [Functional Concept]
   753   C1547052:*Type [Quantitative Concept]
   753   C1704814:Collection [Idea or Concept]
   753   C2242979:Culture [Laboratory Procedure]
   719 E C1706701:Obtain [Activity]

Phrase: "(ATCC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598079:ATCC [Intellectual Product]

Phrase: "Manassas,"

Phrase: "VA)."
Processing 00000000.tx.77: This tau cDNA clone was sequenced and confirmed to contain the complete mouse tau coding region and partial 5' and 3' untranslated sequences. 

Phrase: "This tau cDNA clone"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0009013:Clone [Cell]
   827   C1522642:Clone [Tissue]
   755 E C1704387:Clonal [Qualitative Concept]
   727 E C0796368:clonality [Diagnostic Procedure]

Phrase: "was"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the complete mouse tau coding region"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   840   C0079941:Coding Region [Gene or Genome]
   804   C0009219:Coding [Occupational Activity]
   804   C0017446:Region [Geographic Area]
   804   C0205147:Region [Spatial Concept]
   771 E C0805701:Code [Intellectual Product]
   733 E C0205276:Regional [Spatial Concept]
   733 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "partial 5'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0728938:Partial [Quantitative Concept]
   861   C1550516:partial [Idea or Concept]

Phrase: "and"

Phrase: "3' untranslated sequences."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.78: The cDNA clone was linearized with EcoRI for use as a template to synthesize antisense cRNA probe. 

Phrase: "The cDNA clone"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0009013:Clone [Cell]
   861   C1522642:Clone [Tissue]
   789 E C1704387:Clonal [Qualitative Concept]
   761 E C0796368:clonality [Diagnostic Procedure]

Phrase: "was"

Phrase: "linearized with EcoRI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "for use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "as a template to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0728990:TEMPLATE [Medical Device]
   861   C1514575:Template [Conceptual Entity]
   861   C1705542:Template [Idea or Concept]

Phrase: "synthesize"

Phrase: "antisense cRNA probe."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0182400:Probe [Medical Device]
   827   C1704681:Probe [Gene or Genome]
   827   C2347609:Probe [Chemical Viewed Functionally]
   827   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.79: The cRNA probe synthesis and in situ hybridization protocol were detailed previously (22). 

Phrase: "The cRNA probe synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0220781:synthesis [Biologic Function]
   827   C1883254:Synthesis [Activity]

Phrase: "and"

Phrase: "in situ hybridization protocol"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0442711:Protocol [Intellectual Product]
   812   C1507394:Protocol [Intellectual Product]
   812   C1522729:Protocol [Intellectual Product]
   812   C2348563:Protocol [Intellectual Product]
   756   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "were"

Phrase: "detailed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522508:Detailed [Qualitative Concept]
   966 E C1561567:detail [Functional Concept]

Phrase: "previously"

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.80: After hybridization, slides were exposed to Kodak Bio-Max MR film (Eastman Kodak, Rochester, NY) for 1 d and later dipped in Kodak NTB2 emulsion for 2 d. 

Phrase: "After hybridization,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020202:Hybridisation [Genetic Function]
  1000   C1300517:Hybridization [Laboratory Procedure]

Phrase: "slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0444330:slides [Research Device]
   966 E C1705201:Slide [Manufactured Object]

Phrase: "were"

Phrase: "exposed to Kodak Bio-Max MR film"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0332157:Exposed to [Clinical Attribute]
           Exposed
   748   C0086296:Film [Manufactured Object]
   748   C1561571:film [Biomedical or Dental Material]
   748   C1561572:film [Substance]
   748   C2347167:Mr. [Conceptual Entity]

Phrase: "(Eastman Kodak,"

Phrase: "Rochester,"

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: "for 1 d"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "later"

Phrase: "dipped in Kodak NTB2 emulsion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0014020:Emulsion [Chemical Viewed Structurally]
   760   C0259862:Emulsion [Biomedical or Dental Material]
   726   C3539618:DIP [Gene or Genome]

Phrase: "for 2 d."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1705052:2-D [Spatial Concept]
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]
Processing 00000000.tx.81: Parallel sections were hybridized to sense probes and processed together with antisense hybridization sections to serve as hybridization background control. 

Phrase: "Parallel sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "hybridized"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: "probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0182400:Probes [Medical Device]
   966 E C1704681:Probe [Gene or Genome]
   966 E C2347609:Probe [Chemical Viewed Functionally]
   966 E C3536729:Probe [Manufactured Object]

Phrase: "and"

Phrase: "processed together with antisense hybridization sections to"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   748   C0020202:Hybridisation [Genetic Function]
   748   C1300517:Hybridization [Laboratory Procedure]
   748   C1522240:Processed [Phenomenon or Process]
   748   C1883357:Together [Qualitative Concept]
   714   C0205155:Section [Spatial Concept]
   714 E C1184743:Process [Body Part, Organ, or Organ Component]
   714   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   714   C1522472:Section [Substance]
   714   C1552923:Section [Quantitative Concept]
   714   C1705191:Section [Physical Object]

Phrase: "serve as hybridization background control."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0020202:Hybridisation [Genetic Function]
   760   C0243148:control [Qualitative Concept]
   760   C1300517:Hybridization [Laboratory Procedure]
   760   C1550141:Control [Substance]
   760   C1706907:Background [Conceptual Entity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.82: Background signal from a sense probe was subtracted from raw data before further analysis. 

Phrase: "Background signal from a sense probe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "subtracted from raw data"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0001884:R AW [Organ or Tissue Function]
   770   C1511726:Data [Idea or Concept]
   770   C1709843:Raw [Qualitative Concept]
   770   C3245479:data [Medical Device]
   737   C1719767:Subtract [Intellectual Product]
   737   C2348589:Subtract [Phenomenon or Process]

Phrase: "before further analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.83: Film image was analyzed by NIH image program (Image 1.57, NIH). 

Phrase: "Film image"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1704254:Image [Intellectual Product]
   861   C1704922:Image [Entity]
   861   C3542466:Image [Intellectual Product]

Phrase: "was"

Phrase: "analyzed by NIH image program"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0027468:NIH [Health Care Related Organization]
   760   C0936012:Analyzed [Research Activity]
   760   C1704254:Image [Intellectual Product]
   760   C1704922:Image [Entity]
   760   C1709697:Program [Conceptual Entity]
   760   C2728259:Program [Pharmacologic Substance]
   760   C3484370:Program [Functional Concept]
   760   C3542466:Image [Intellectual Product]

Phrase: "(Image 1.57,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "NIH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027468:NIH [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.84: The quantitation of hybridization signal was carried out in a blinded fashion. 

Phrase: "The quantitation of hybridization signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709793:Quantitation [Quantitative Concept]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in a blinded fashion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0150108:Blinded [Research Activity]
   760   C0439787:Out [Spatial Concept]
   760   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.85: Four measurements in each brain structure, including frontal cortex, thalamus and granule cell layer of cerebellum were taken for each animal to obtain group means. 

Phrase: "Four measurements in each brain structure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0242485:measurements [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "frontal cortex,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C0205123:Frontal [Spatial Concept]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "thalamus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039729:Thalamus [Body Part, Organ, or Organ Component]
  1000   C1269896:Thalamus [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "granule cell layer of cerebellum"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C1283325:Layer of cerebellum [Body Part, Organ, or Organ Component]
   762   C0221923:Granular Layer [Tissue]
   760   C0934502:Layer [Body Part, Organ, or Organ Component]
   760   C1522408:Layer [Qualitative Concept]
   760   C1561599:Layer [Intellectual Product]

Phrase: "were"

Phrase: "taken for each animal to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0003062:Animal [Animal]
   760   C1883727:Taken [Conceptual Entity]
   726 E C1515187:Take [Health Care Activity]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "group means."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1704970:Means [Conceptual Entity]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   827 E C0444504:Mean [Quantitative Concept]
   827 E C2347634:Mean [Quantitative Concept]
   827 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.86: Hybridization signals on CA2 and CA3 of hippocampus were captured using a monochrome video camera under x400 magnification and silver grains were counted with assistance of NIH image version 1.57 software. 

Phrase: "Hybridization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020202:Hybridisation [Genetic Function]
  1000   C1300517:Hybridization [Laboratory Procedure]

Phrase: "signals on CA2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   790   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "CA3 of hippocampus"

Phrase: "were"

Phrase: "captured"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a monochrome video camera under x400 magnification"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0179547:video camera [Medical Device]
   748   C0042655:Video [Manufactured Object]
   748   C0179533:Camera [Medical Device]
   748   C1654607:Camera [Eukaryote]
   748   C1706254:CAMERA [Medical Device]
   748   C3463807:Video [Intellectual Product]

Phrase: "and"

Phrase: "silver grains"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0007757:Grains [Food]
   861   C0086369:Grains [Plant]
   827 E C1552950:Grain [Quantitative Concept]

Phrase: "were"

Phrase: "counted with assistance of NIH image version 1.57 software."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   739   C0018896:Assistance [Social Behavior]
   739   C0027468:NIH [Health Care Related Organization]
   739   C0037585:Software [Intellectual Product,Manufactured Object]
   739   C0333052:Version [Functional Concept]
   739   C1704254:Image [Intellectual Product]
   739   C1704922:Image [Entity]
   739   C2607870:Version [Spatial Concept]
   739   C3542466:Image [Intellectual Product]
   706   C0750480:Count [Activity]
   706   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.87: Statistical significance between two groups was compared by ANOVA followed by Fishers least significant different tests (n = 4 for Igf1/ brains and n = 5 for WT control).  

Phrase: "Statistical significance between two groups"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0237881:Statistical Significance [Quantitative Concept]
           Significance
   806   C1709380:Statistical Significance [Quantitative Concept]
   760   C0038215:Statistical [Occupation or Discipline]
   760   C0750502:Significance [Idea or Concept]

Phrase: "was"

Phrase: "compared by ANOVA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "followed by Fishers least significant different tests"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0022885:Tests [Laboratory Procedure]
   748   C0237881:significant [Quantitative Concept]
   748   C0392366:Tests [Intellectual Product]
   748   C0750502:Significant [Idea or Concept]
   748   C1546944:Significant [Qualitative Concept]
   748   C1705242:Different [Qualitative Concept]
   741   C1708064:Fisher's Test [Intellectual Product]
   714 E C0039593:Test [Functional Concept]
   714   C0325045:Fisher [Mammal]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "(n = 4 for Igf1/ brains"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   781   C1418764:BRAIN-4 [Gene or Genome]
   760   C0006104:Brains [Body Part, Organ, or Organ Component]
   760   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0202220:IGF1 [Laboratory Procedure]
   760   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441922:N+ [Intellectual Product]
   760   C1334089:IGF I [Gene or Genome]
   760   C1553036:[n] [Quantitative Concept]
   760   C1708414:IGFI [Gene or Genome]
   726 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "n = 5 for WT control"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   790   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   790   C1883559:Wild Type [Organism Attribute]
   783   C0457499:Type 5 [Intellectual Product]
   783   C1707504:Control Type [Research Activity]
   783   C1879930:Control Type [Intellectual Product]
   753   C0243148:control [Qualitative Concept]
   753   C0332307:Type [Qualitative Concept]
   753   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441922:N+ [Intellectual Product]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
   753   C1550141:Control [Substance]
   753   C1553036:[n] [Quantitative Concept]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.88: Results Top Abstract Introduction Materials and Methods Results Discussion References  IGF-I null mice The Igf1/ mice have a very high perinatal mortality, largely due to hypoventilation (19). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "IGF-I null mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C0206745:Null Mouse [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "The Igf1/ mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "have"

Phrase: "a very high perinatal mortality,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0031062:Perinatal Mortality [Group Attribute]
   861   C0701826:Perinatal mortality [Finding]
   812   C0026565:Mortality [Quantitative Concept]
   812   C0026566:mortality [Quantitative Concept]
   812   C0178795:Perinatal [Temporal Concept]

Phrase: "largely due to hypoventilation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0678226:Due to [Functional Concept]
           due
   770   C0398353:hypoventilation [Pathologic Function]
   770   C3146286:Due [Idea or Concept]
   770   C3203358:Hypoventilation [Pathologic Function]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.89: The mice that survive are dwarfs, reaching approximately 3040% of WT size, depending on the strain (23). 

Phrase: "The mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "survive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0310255:SURVIVE [Pharmacologic Substance]

Phrase: "are"

Phrase: "dwarfs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013336:dwarfs [Congenital Abnormality,Disease or Syndrome]

Phrase: "reaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reaching [Organism Function]

Phrase: "approximately 3040% of WT size,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0332232:Approximately [Qualitative Concept]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C0456389:size [Spatial Concept]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "depending on the strain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0080194:Strain [Injury or Poisoning]
   770   C0456178:strain [Intellectual Product]
   770   C1518614:Strain [Organism]
   770   C2987481:Strain [Mental Process]
   737   C0725813:depend [Medical Device]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.90: Whereas behavior is difficult to measure precisely in dwarfs, our study did not find any evidence for major neurological defects (20). 

Phrase: "Whereas"

Phrase: "behavior"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0004927:Behavior [Individual Behavior]
  1000   C2707008:Behavior [Clinical Attribute]
   928 E C2986890:Behavioral [Idea or Concept]

Phrase: "is"

Phrase: "difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "precisely in dwarfs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0013336:dwarfs [Congenital Abnormality,Disease or Syndrome]

Phrase: "our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "any evidence for major neurological defects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332120:Evidence [Functional Concept]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.91: Lipofuscin Accumulation of autofluorescent lipoprotein pigments (lipofuscin) in nerve cells is a typical feature of brain aging. 

Phrase: "Lipofuscin Accumulation of autofluorescent lipoprotein pigments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0333638:Lipofuscin accumulation [Pathologic Function]
   767   C1624584:pigment accumulation [Organism Function]

Phrase: "(lipofuscin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023789:Lipofuscin [Biologically Active Substance,Lipid]

Phrase: ")"

Phrase: "in nerve cells"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0027882:Nerve Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0027740:Nerve [Tissue]
   861   C0027757:NERVE [Tissue]
   861   C1280541:Nerve [Body Part, Organ, or Organ Component]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   805 E C0599851:Neural [Functional Concept]
   789 E C0027769:nervy [Sign or Symptom]

Phrase: "is"

Phrase: "a typical feature of brain aging."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1521970:Feature [Qualitative Concept]
   753   C1706388:Feature [Conceptual Entity]
   753   C2346469:Feature [Qualitative Concept]
   753   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.92: Thus, we examined whether IGF-I deletion affected the lipofuscin deposition in aged brains by comparing sections from Igf1 gene-deleted and age-matched WT mice. 

Phrase: "Thus,"

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "IGF-I deletion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1442161:Deletion [Cell or Molecular Dysfunction]
   827   C1511760:Deletion [Genetic Function]
   827   C1880274:Deletion [Activity]
   734   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1334089:IGF I [Gene or Genome]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the lipofuscin deposition in aged brains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0333562:Deposition [Functional Concept]

Phrase: "by comparing sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "from Igf1 gene-deleted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1880274:Deleted [Activity]
   734   C1334089:IGF1 gene [Gene or Genome]

Phrase: "and"

Phrase: "age-matched WT mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   851   C1520150:Wild Type Mouse [Mammal]
   840   C1883559:Wild Type [Organism Attribute]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   804   C0332307:Type [Qualitative Concept]
   804   C0445392:Wild [Intellectual Product]
   804   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.93: There were no apparent differences in the distribution or levels of autofluorescent signals in 400-d-old Igf1/ brains compared with WT control brains (Fig. 1). 

Phrase: "There"

Phrase: "were"

Phrase: "no apparent differences in the distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "or"

Phrase: "levels of autofluorescent signals"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in 400-"

Phrase: "d-"

Phrase: "old Igf1/ brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "compared with WT control brains"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   790   C1883559:Wild Type [Organism Attribute]
   783   C0596948:brains control [Mental Process]
   783   C1707504:Control Type [Research Activity]
   783   C1879930:Control Type [Intellectual Product]
   753   C0006104:Brains [Body Part, Organ, or Organ Component]
   753   C0243148:control [Qualitative Concept]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
   753   C1550141:Control [Substance]
   753   C1707455:Compared [Activity]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   719 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.94: This result was confirmed by lipid staining using Sudan Black B (data not shown). 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "was"

Phrase: "confirmed by lipid staining"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   770   C0023779:Lipid [Lipid]
   770   C0487602:Staining [Laboratory Procedure]
   770   C0750484:Confirmed [Idea or Concept]
   770   C1704680:Staining [Finding]
   737 E C1456348:Confirm [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Sudan Black B"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0075489:Sudan Black B [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0005680:Black [Population Group]
   827   C0027567:Black [Population Group]
   827   C0038642:Sudan [Geographic Area]
   827   C0085756:Black [Population Group]
   827   C0439541:Black [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.95: View larger version (102K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(102K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.96: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.97: Lipofuscin deposition in the aged Igf1/ (B, D, and F) and WT (A, C, and E) brains. 

Phrase: "Lipofuscin deposition in the aged Igf1/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0333562:Deposition [Functional Concept]

Phrase: "(B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "F)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "(A,"

Phrase: "C,"

Phrase: "and"

Phrase: "E) brains."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.98: Fluorescent micrographs show similar lipofuscin deposition (yellow) in both Igf1/ and WT brains. 

Phrase: "Fluorescent micrographs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   755   C0240341:Micrographia [Finding]
   755   C0596928:micrography [Laboratory Procedure]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "similar lipofuscin deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333562:Deposition [Functional Concept]

Phrase: "(yellow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221205:Yellow [Qualitative Concept]

Phrase: ")"

Phrase: "in both Igf1/"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0202220:IGF1 [Laboratory Procedure]
  1000   C1334089:IGF I [Gene or Genome]
  1000   C1708414:IGFI [Gene or Genome]

Phrase: "and"

Phrase: "WT brains."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.99: Nuclei are revealed by DAPI staining (blue). 

Phrase: "Nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]

Phrase: "are"

Phrase: "revealed by DAPI staining"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0057142:DAPI [Organic Chemical,Pharmacologic Substance]
   770   C0443289:Revealed [Qualitative Concept]
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]

Phrase: "(blue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260957:Blue [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.100: AD, Representative micrographs showing lipofuscin fluorescence concentrated in Purkinje cells of the cerebellar cortex, with C and D at higher magnification. 

Phrase: "AD,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "Representative micrographs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   755   C0240341:Micrographia [Finding]
   755   C0596928:micrography [Laboratory Procedure]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "lipofuscin fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "concentrated in Purkinje cells of the cerebellar cortex,"
Meta Candidates (Total=18; Excluded=5; Pruned=0; Remaining=13)
   776   C0034143:cerebellar Purkinje cell [Cell]
           Purkinje Cells
   770   C0007759:Cerebellar Cortex [Body Part, Organ, or Organ Component]
   770   C1284087:Cerebellar cortex [Body Part, Organ, or Organ Component]
   750   C1166657:cell cortex [Cell Component]
   744   C0007634:Cells [Cell]
   744   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   744   C0007776:Cortex [Body Part, Organ, or Organ Component]
   744   C1176472:Cortex [Body Part, Organ, or Organ Component]
   744   C1707522:Cerebellar [Tissue]
   744   C1880165:Concentrated [Biomedical or Dental Material]
   744   C2700441:Cortex [Plant]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1880310:Concentrate [Manufactured Object]
   711 E C1948049:Cell [Spatial Concept]
   711 E C2003864:Concentrate [Substance]

Phrase: "with C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "D at higher magnification."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.101: E and F, Lipofuscin in frontal cortex.  

Phrase: "E"

Phrase: "and"

Phrase: "F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Lipofuscin in frontal cortex."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0023789:Lipofuscin [Biologically Active Substance,Lipid]
Processing 00000000.tx.102: Nitrotyrosine residues To address whether IGF-I modulates brain oxidative stress, we investigated the deposition of nitrotyrosine residues (NT), the end-products of oxidative reactions. 

Phrase: "Nitrotyrosine residues To"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "whether"

Phrase: "IGF-I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:IGF I [Gene or Genome]
   861   C0021966:I- [Inorganic Chemical]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "brain oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   827   C0311404:Oxidative [Functional Concept]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the deposition of nitrotyrosine residues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0333562:Deposition [Functional Concept]

Phrase: "(NT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332126:NT [Qualitative Concept]
  1000   C1449832:NT [Diagnostic Procedure]

Phrase: ")"

Phrase: ","

Phrase: "the end-products of oxidative reactions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0444930:End [Spatial Concept]
   753   C1514468:Products [Entity]
   753   C2746065:End [Temporal Concept]
   719 E C1704444:Product [Quantitative Concept]
Processing 00000000.tx.103: We found that NT distribution was similar in Igf1/ and WT brains (Fig. 2). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that NT distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: "was"

Phrase: "similar in Igf1/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "WT brains"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.104: For example, NT immunostaining was apparent in Purkinje cells (Fig. 2, A and B) and in pyramidal neurons of the cerebral cortex (Fig. 2, C and D). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "NT immunostaining"

Phrase: "was"

Phrase: "apparent in Purkinje cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0750489:apparent [Idea or Concept]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and in pyramidal neurons of the cerebral cortex"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   808   C2333134:Neuron of cerebral cortex [Cell]
   770   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   744   C0027882:Neurons [Cell]
   744   C1176472:Cortex [Body Part, Organ, or Organ Component]
   744   C1515981:And [Idea or Concept]
   744   C2700441:Cortex [Plant]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.105: The intensity of the immunostaining appeared similar in Purkinje cells, although they were markedly smaller in the Igf1/ brain. 

Phrase: "The intensity of the immunostaining appeared similar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0522510:Intensity [Qualitative Concept]

Phrase: "in Purkinje cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0034143:Purkinje Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "although"

Phrase: "they"

Phrase: "were"

Phrase: "markedly smaller in the Igf1/ brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C3151998:Small brain [Finding]
   753   C0547044:Smaller [Qualitative Concept]
   753   C0700321:Smaller [Quantitative Concept]
Processing 00000000.tx.106: Semiquantitation of immunostaining in cortical pyramids suggested a modest but significant increase in NT accumulation (P = 0.03) in cortical layer IV/V of Igf1/ brains (Fig. 2E). 

Phrase: "Semiquantitation of immunostaining"

Phrase: "in cortical pyramids"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0262324:pyramids [Body Part, Organ, or Organ Component]
   827 E C1521969:Pyramid [Body Part, Organ, or Organ Component]
   827 E C2362572:Pyramid [Anatomical Structure]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a modest"

Phrase: "but"

Phrase: "significant increase in NT accumulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "(P = 0.03"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in cortical layer IV/V"

Phrase: "of Igf1/ brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 2E"

Phrase: ")."
Processing 00000000.tx.107: However, NT levels were similar in Igf1/ and WT brains in the thalamus, hypothalamus, striatum, and cerebellum (not shown). 

Phrase: "However,"

Phrase: "NT levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "similar in Igf1/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "WT brains in the thalamus,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0039729:BRAIN, THALAMUS [Body Part, Organ, or Organ Component]
   753   C0006104:Brains [Body Part, Organ, or Organ Component]
   719 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "hypothalamus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020663:Hypothalamus [Body Part, Organ, or Organ Component]
  1000   C1280712:Hypothalamus [Body Part, Organ, or Organ Component]

Phrase: "striatum,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010097:Striatum [Body Part, Organ, or Organ Component]
  1000   C0162512:Striatum [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "cerebellum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.108: View larger version (101K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(101K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.109: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.110: Comparison of nitrotyrosine residue (NT) levels in the aged Igf1/ and WT brains. 

Phrase: "Comparison of nitrotyrosine residue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Comparison [Activity]

Phrase: "(NT) levels in the aged Igf1/"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "WT brains."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.111: Representative micrographs showed NT immunostaining concentrated in Purkinje cells (arrows) of the cerebellar cortex (A and B) and pyramidal neurons of the cerebral cortex (C and D) in Igf1/ (A and C) and WT (B and D) brains. 

Phrase: "Representative micrographs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   755   C0240341:Micrographia [Finding]
   755   C0596928:micrography [Laboratory Procedure]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "NT immunostaining"

Phrase: "concentrated in Purkinje cells"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   833   C0034143:Purkinje Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C1880165:Concentrated [Biomedical or Dental Material]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1880310:Concentrate [Manufactured Object]
   737 E C1948049:Cell [Spatial Concept]
   737 E C2003864:Concentrate [Substance]

Phrase: "(arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: ")"

Phrase: "of the cerebellar cortex"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007759:Cerebellar Cortex [Body Part, Organ, or Organ Component]
  1000   C1284087:Cerebellar cortex [Body Part, Organ, or Organ Component]
   861   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C1707522:Cerebellar [Tissue]
   861   C2700441:Cortex [Plant]

Phrase: "(A"

Phrase: "and"

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "pyramidal neurons of the cerebral cortex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   846   C2333134:Neuron of cerebral cortex [Cell]
   753   C0027882:Neurons [Cell]

Phrase: "(C"

Phrase: "and"

Phrase: "D) in Igf1/"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0202220:IGF1 [Laboratory Procedure]
   790   C1334089:IGF I [Gene or Genome]
   790   C1708414:IGFI [Gene or Genome]

Phrase: "(A"

Phrase: "and"

Phrase: "C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "D)"

Phrase: "brains."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.112: The cellular expression and distribution patterns of NT were similar in most brain regions. 

Phrase: "The cellular expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "distribution patterns of NT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0449775:distribution patterns [Spatial Concept]
   770   C0449774:Patterns [Spatial Concept]

Phrase: "were"

Phrase: "similar in most brain regions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.113: The results of semiquantitative analyses of the NT immunosignal in different brain regions are graphed in panel E.  

Phrase: "The results of semiquantitative analyses of the NT immunosignal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708   C2825142:Result [Finding]

Phrase: "in different brain regions"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C1273723:brain regions [Body Location or Region]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "are"

Phrase: "graphed in panel E."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0441833:Panel [Idea or Concept]
   770   C1999270:Panel [Intellectual Product]
   770   C3537156:Panel [Manufactured Object]
   737   C0681493:Graph [Intellectual Product]
   737   C2698021:Graph [Conceptual Entity]
Processing 00000000.tx.114: Oxidation regulatory enzymes We also evaluated enzymes involved in production of nitric oxide, nitric oxide synthetases (NOS) in these brains by immunoblotting (Fig. 3). 

Phrase: "Oxidation regulatory enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014442:Enzymes [Enzyme,Organic Chemical]
   827   C0014445:enzymes [Functional Concept]

Phrase: "We also evaluated enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014442:Enzymes [Enzyme,Organic Chemical]
   827   C0014445:enzymes [Functional Concept]

Phrase: "involved in production of nitric oxide,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C0030015:oxide [Inorganic Chemical]
   753   C0033268:production [Occupational Activity]
   753   C1314939:Involved [Functional Concept]
   753   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "nitric oxide synthetases"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0132555:Nitric-Oxide Synthetase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0023689:Synthetases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0030015:oxide [Inorganic Chemical]
   827   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "(NOS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   901   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0030015:oxide [Inorganic Chemical]
   827   C2986642:oxide [Chemical Viewed Functionally]

Phrase: ")"

Phrase: "in these brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "by immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.115: We found similar levels of nNOS and iNOS in Igf1/ and WT brains. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "similar levels of nNOS"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "iNOS in Igf1/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1518425:{NOS} [Qualitative Concept]

Phrase: "and"

Phrase: "WT brains."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.116: There was a trend toward higher iNOS levels in Igf1/ brains, but the difference between groups did not reach statistical significant (Fig. 3). 

Phrase: "There"

Phrase: "was"

Phrase: "a trend toward higher iNOS levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1521798:trend [Temporal Concept]

Phrase: "in Igf1/ brains,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "but"

Phrase: "the difference between groups"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "statistical significant"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   964   C0237881:Statistical Significance [Quantitative Concept]
           significant
   964   C1709380:Statistical Significance [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.117: SOD1 levels were also similar in Igf1/ and WT brains (Fig. 3). 

Phrase: "SOD1 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "also similar in Igf1/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "WT brains"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.118: View larger version (35K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(35K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.119: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.120: NOS and SOD in aged Igf1/ and WT brains. 

Phrase: "NOS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   901   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0030015:oxide [Inorganic Chemical]
   827   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "and"

Phrase: "SOD in aged Igf1/"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0038838:Superoxide Dismutase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0038836:Superoxide [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "WT brains."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.121: Immunoblotting analysis revealed no significant difference in the levels on nNOS or iNOS between aged Igf1/ and WT brains, although iNOS levels were slightly higher in Igf1/ brains, the difference did not reach statistical significance. 

Phrase: "Immunoblotting analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C0020985:Immunoblot Analysis [Laboratory Procedure]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "no significant difference in the levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "on nNOS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0521390:Neuronal [Immunologic Factor]
   861   C1518425:{NOS} [Qualitative Concept]
   789 E C0027882:Neuron [Cell]

Phrase: "or"

Phrase: "iNOS between aged Igf1/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1518425:{NOS} [Qualitative Concept]

Phrase: "and"

Phrase: "WT brains,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "although"

Phrase: "iNOS levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "slightly higher in Igf1/ brains,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "the difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "statistical significance."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:Statistical Significance [Quantitative Concept]
           Significance
  1000   C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistical [Occupation or Discipline]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.122: Immunoblotting also revealed similar SOD1 levels in Igf1/ and WT brains. 

Phrase: "Immunoblotting also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "similar SOD1 levels in Igf1/"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "WT brains."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.123: Protein bands from the blots were quantified using computer-assistant image analysis. 

Phrase: "Protein bands from the blots"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0175723:Bands [Medical Device]
   726 E C0439645:Band [Spatial Concept]
   726 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "quantified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "computer-assistant image analysis."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   902   C1516770:Computer Analysis [Machine Activity]
   861   C0200765:Image analysis [Laboratory Procedure]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]
   812   C1704254:Image [Intellectual Product]
   812   C1704922:Image [Entity]
   812   C3542466:Image [Intellectual Product]
Processing 00000000.tx.124: Data were expressed as mean  SEM of percentage of WT values (n = 4 for Igf1/ and n = 5 for WT brains).  

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "expressed as mean  SEM of percentage of WT values"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   760   C1883559:Wild Type [Organism Attribute]
   741   C1550401:Value type [Idea or Concept]
   739   C0042295:Values [Qualitative Concept]
   739   C0332307:Type [Qualitative Concept]
   739   C0439165:Percentage [Quantitative Concept]
   739   C0444504:Mean [Quantitative Concept]
   739   C0445392:Wild [Intellectual Product]
   739   C1547052:*Type [Quantitative Concept]
   739   C1549488:Percentage [Idea or Concept]
   739   C1561533:Percentage [Idea or Concept]
   739   C2347634:Mean [Quantitative Concept]
   739   C2348143:Mean [Quantitative Concept]
   706 E C1522609:Value [Quantitative Concept]

Phrase: "(n = 4 for Igf1/"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0202220:IGF1 [Laboratory Procedure]
   770   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441922:N+ [Intellectual Product]
   770   C1334089:IGF I [Gene or Genome]
   770   C1553036:[n] [Quantitative Concept]
   770   C1708414:IGFI [Gene or Genome]

Phrase: "and"

Phrase: "n = 5 for WT brains"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   790   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   790   C1883559:Wild Type [Organism Attribute]
   783   C0457499:Type 5 [Intellectual Product]
   753   C0006104:Brains [Body Part, Organ, or Organ Component]
   753   C0332307:Type [Qualitative Concept]
   753   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441922:N+ [Intellectual Product]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
   753   C1553036:[n] [Quantitative Concept]
   719 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.125: Tau NFTs accumulate during brain aging as a result of increased phosphorylation of the microtubule-associated protein tau (17). 

Phrase: "Tau NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   901   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   867 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "accumulate during brain aging"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0001811:Ageing [Organism Function]
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   737 E C0001779:Age [Organism Attribute]

Phrase: "as a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "of increased phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "of the microtubule-associated protein tau"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1446659:MICROTUBULE-ASSOCIATED PROTEIN TAU [Gene or Genome]
  1000   C2700455:Microtubule-Associated Protein Tau [Amino Acid, Peptide, or Protein]
   923   C0026045:Microtubule-associated protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0085401:Microtubule protein tau [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1421563:protein tau [Gene or Genome]
   812   C0026046:Micro-tubule [Cell Component]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332281:Associated [Qualitative Concept]
   812   C1720655:Tau [Intellectual Product]
   812   C1947974:Tau [Research Activity]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.126: To examine the effect of IGF-I deletion on tau phosphorylation in aged brains, we used Western blotting to evaluate the phosphorylation status of tau in Igf1/ and WT brains. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the effect of IGF-I deletion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on tau phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "in aged brains,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Western blotting to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   884 E C0949466:Western Blot [Laboratory Procedure]
   827   C1705493:Western [Spatial Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the phosphorylation status of tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449438:Status [Qualitative Concept]

Phrase: "in Igf1/"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0202220:IGF1 [Laboratory Procedure]
  1000   C1334089:IGF I [Gene or Genome]
  1000   C1708414:IGFI [Gene or Genome]

Phrase: "and"

Phrase: "WT brains."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.127: Anti-tau-396 antibodies recognize tau phosphorylated at serine 396, a site predominantly phosphorylated by GSK-3 (glycogen synthase kinase 3) and prominent in pathological paired helical filaments (PHF) of neurofibrillary tangles (24). 

Phrase: "Anti-tau-396 antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   902   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   886 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "recognize"

Phrase: "tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "phosphorylated at serine 396,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "a site predominantly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "phosphorylated by GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   882   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(glycogen synthase kinase 3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "and"

Phrase: "prominent in pathological paired helical filaments (PHF) of neurofibrillary tangles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205402:Prominent [Qualitative Concept]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.128: Tau phosphorylation at this specific epitope was increased by approximately 7-fold in the Igf1/ brain compared with WT (P = 0.004) (Fig. 4). 

Phrase: "Tau phosphorylation at this specific epitope"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "increased by approximately 7-fold"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205217:Increased [Quantitative Concept]
   760   C0332232:Approximately [Qualitative Concept]
   760   C0332462:Fold [Spatial Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1880834:FOLD [Phenomenon or Process]

Phrase: "in the Igf1/ brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "compared with WT"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1547052:*Type [Quantitative Concept]
   770   C1707455:Compared [Activity]

Phrase: "(P = 0.004"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.129: Another phospho-tau-specific antibody, AT-8, which recognizes PHF-associated tau, phosphorylated at serine 202, also detected a significant approximately 10-fold increased in Igf1/ brain homogenate compared with WTs (P = 0.02). 

Phrase: "Another phospho-tau-specific antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "AT-8,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516077:At [Spatial Concept]

Phrase: "which"

Phrase: "recognizes"

Phrase: "PHF-associated tau,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C2700455:Paired Helical Filament-Tau [Amino Acid, Peptide, or Protein]
   799   C1720655:Tau [Intellectual Product]
   799   C1947974:Tau [Research Activity]

Phrase: "phosphorylated at serine 202,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "also"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "a significant approximately 10-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332462:Fold [Spatial Concept]
   812   C1880834:FOLD [Phenomenon or Process]

Phrase: "increased in Igf1/ brain homogenate"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0202220:IGF1 [Laboratory Procedure]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1334089:IGF I [Gene or Genome]
   760   C1708414:IGFI [Gene or Genome]

Phrase: "compared with WTs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1421524:WTS [Gene or Genome]
   790   C1705714:WTS [Gene or Genome]
   790   C1707455:Compared [Activity]
   790   C1839736:WTS [Disease or Syndrome]

Phrase: "(P = 0.02"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.130: However, tau phosphorylation at serine 262 detected by 12E8 antibody showed no difference between Igf1/ and WT brains. 

Phrase: "However,"

Phrase: "tau phosphorylation at serine 262"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "detected by 12E8 antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no difference between Igf1/"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "WT brains."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.131: Total tau levels detected by the phospho-independent antibody, tau-5, were similar in Igf1/ and WT brains (Fig. 4). 

Phrase: "Total tau levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "detected by the phospho-independent antibody,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0085862:Independent [Idea or Concept]
   753   C0442726:Detected [Finding]
   753   C1299583:Independent [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "tau-5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "were"

Phrase: "similar in Igf1/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "WT brains"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.132: Consistent with the above observations, the nonphosphorylated tau population, as detected by anti-tau-1 antibody (25, 26), was reduced in the Igf1/ aged brains (P < 0.01). 

Phrase: "Consistent with the above observations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "the nonphosphorylated tau population,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]

Phrase: "as"

Phrase: "detected by anti-tau-1 antibody"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0250875:tau-1 [Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]

Phrase: "(25,"

Phrase: "26"

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "reduced in the Igf1/ aged brains"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   753   C0001779:Aged [Organism Attribute]
   753   C0001792:Aged [Population Group]
   753   C0006104:Brains [Body Part, Organ, or Organ Component]
   753   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0202220:IGF1 [Laboratory Procedure]
   753   C0392756:Reduced [Qualitative Concept]
   753   C1334089:IGF I [Gene or Genome]
   753   C1708414:IGFI [Gene or Genome]
   753   C1999167:aged [Population Group]
   719 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.133: This result shows that tau is heavily phosphorylated on two serine sites in the brains of animals with IGF-I deficiency, suggesting that IGF-I normally prevents tau hyperphosphorylation at these specific sites. 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "heavily"

Phrase: "phosphorylated on two serine sites"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0205145:Sites [Spatial Concept]
   760   C0205448:Two [Quantitative Concept]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]

Phrase: "in the brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "with IGF-I deficiency,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0011155:Deficiency [Functional Concept]
   827   C0162429:Deficiency [Disease or Syndrome]
   827   C1623416:deficiency [Qualitative Concept]
   755 E C1636779:% deficient [Quantitative Concept]
   734   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1334089:IGF I [Gene or Genome]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that IGF-I normally"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1334089:IGF I [Gene or Genome]
   827   C0021966:I- [Inorganic Chemical]
   827   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "tau hyperphosphorylation at these specific sites."
Processing 00000000.tx.134: View larger version (61K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(61K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.135: 4. 

Phrase: "4."
Processing 00000000.tx.136: Hyperphosphorylation of tau in the Igf1/ brain. 

Phrase: "Hyperphosphorylation of tau"

Phrase: "in the Igf1/ brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.137: Total and phospho-tau immunoreactivity were examined in aged Igf1/ and WT brains by immunoblots. 

Phrase: "Total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "phospho-tau immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597879:immunoreactivity [Molecular Function]

Phrase: "were"

Phrase: "examined in aged Igf1/"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0001779:Aged [Organism Attribute]
   770   C0001792:Aged [Population Group]
   770   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0202220:IGF1 [Laboratory Procedure]
   770   C0332128:Examined [Finding]
   770   C1334089:IGF I [Gene or Genome]
   770   C1708414:IGFI [Gene or Genome]
   770   C1999167:aged [Population Group]

Phrase: "and"

Phrase: "WT brains by immunoblots."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0006104:Brains [Body Part, Organ, or Organ Component]
   726 E C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.138: A, Total tau was detected by anti-tau-5, which recognizes tau protein irrespective of its phosphorylation status. 

Phrase: "A,"

Phrase: "Total tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "was"

Phrase: "detected by anti-tau-5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]

Phrase: "which"

Phrase: "recognizes"

Phrase: "tau protein irrespective of its phosphorylation status."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   774   C1158886:Protein phosphorylation [Molecular Function]
   774 E C1421563:protein tau [Gene or Genome]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]
Processing 00000000.tx.139: This exact blot was striped and reprobed with antibody AT-8 that recognizes PHF-tau with phosphorylated ser202 residue and later reprobed with antibody 12E8 that recognized phosphor-tau at ser 262. 

Phrase: "This exact blot"

Phrase: "was"

Phrase: "striped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1532935:Striped [Qualitative Concept]

Phrase: "and"

Phrase: "reprobed with antibody AT-8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "that"

Phrase: "recognizes"

Phrase: "PHF-tau with phosphorylated ser202 residue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   801   C2700455:Paired Helical Filament-Tau [Amino Acid, Peptide, or Protein]
   742   C1720655:Tau [Intellectual Product]
   742   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "later"

Phrase: "reprobed with antibody 12E8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "that recognized phosphor-tau at ser 262."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]
Processing 00000000.tx.140: B, In another independent trial, phospho-tau was detected by antibody p-tau-396, that specifically recognizes tau phosphorylation on serine 396, a site prominently phosphorylated in PHF-tau. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "In another independent trial,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008976:Trial [Research Activity]

Phrase: "phospho-tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "was"

Phrase: "detected by antibody p-tau-396,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]

Phrase: "that specifically"

Phrase: "recognizes"

Phrase: "tau phosphorylation on serine 396,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "a site prominently"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "phosphorylated in PHF-tau."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   837   C2700455:Paired Helical Filament-Tau [Amino Acid, Peptide, or Protein]
   780   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   748   C0030664:Pathological [Biomedical Occupation or Discipline]
   748   C1521733:Pathological [Functional Concept]
   748   C1709450:Paired [Qualitative Concept]
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]
   714   C0010851:Filament [Cell Component]
Processing 00000000.tx.141: The same blot was then stripped and reprobed with tau-1 antibody, which detects dephosphorylated tau. 

Phrase: "The same blot"

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "stripped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1321564:Strip [Medical Device]

Phrase: "and"

Phrase: "reprobed with tau-1 antibody,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0250875:tau-1 [Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]

Phrase: "which"

Phrase: "detects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "dephosphorylated tau."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]
Processing 00000000.tx.142: These blots show that total tau protein is preserved in Igf1/ brain, whereas tau phosphorylation is dramatically increased in aged Igf1/ brains compared with WTs.  

Phrase: "These blots"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that total tau protein"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C2827505:Total Tau Protein [Laboratory Procedure]
   913   C0555903:Total protein [Laboratory Procedure]
   913   C1261360:total protein [Laboratory or Test Result]
   901   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "preserved in Igf1/ brain,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0033085:Preserved [Laboratory Procedure]
   770   C0202220:IGF1 [Laboratory Procedure]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1334089:IGF I [Gene or Genome]
   770   C1708414:IGFI [Gene or Genome]

Phrase: "whereas"

Phrase: "tau phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "is"

Phrase: "dramatically"

Phrase: "increased in aged Igf1/ brains"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   760   C0001779:Aged [Organism Attribute]
   760   C0001792:Aged [Population Group]
   760   C0006104:Brains [Body Part, Organ, or Organ Component]
   760   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0202220:IGF1 [Laboratory Procedure]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1334089:IGF I [Gene or Genome]
   760   C1708414:IGFI [Gene or Genome]
   760   C1999167:aged [Population Group]
   726 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "compared with WTs."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1421524:WTS [Gene or Genome]
   790   C1705714:WTS [Gene or Genome]
   790   C1707455:Compared [Activity]
   790   C1839736:WTS [Disease or Syndrome]
Processing 00000000.tx.143: To further investigate tau expression in Igf1/ and WT mice, we performed in situ hybridization on anatomically matched brain sections. 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "tau expression in Igf1/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "WT mice,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "in situ hybridization on anatomically matched brain sections."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   800   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   770   C0444498:In situ [Spatial Concept]
   744   C0020202:Hybridisation [Genetic Function]
   744   C1300517:Hybridization [Laboratory Procedure]
Processing 00000000.tx.144: The anatomical distribution of tau mRNA was similar in Igf1/ and WT mice (Fig. 5). 

Phrase: "The anatomical distribution of tau mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "was"

Phrase: "similar in Igf1/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "WT mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.145: Tau mRNA was concentrated in the dentate gyrus and Ammons horn (Fig. 5, A and B) and in the granule cell layer as well as Purkinje cells of cerebellum (Fig. 5, C and D). 

Phrase: "Tau mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "concentrated in the dentate gyrus"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0152314:Dentate Gyrus [Body Part, Organ, or Organ Component]
   806   C1281026:Dentate gyrus [Body Part, Organ, or Organ Component]
   760   C1880165:Concentrated [Biomedical or Dental Material]
   726 E C1880310:Concentrate [Manufactured Object]
   726 E C2003864:Concentrate [Substance]

Phrase: "and"

Phrase: "Ammons horn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019564:Ammons Horn [Body Part, Organ, or Organ Component]
   861   C0019939:Horn [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and in the granule cell layer"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   790   C0596630:granule cell [Cell]
   783 E C0010837:Cell granule [Cell Component]
           Granule
   753   C0007634:Cell [Cell]
   753   C0934502:Layer [Body Part, Organ, or Organ Component]
   753   C0993609:Granule [Biomedical or Dental Material]
   753   C1269647:Cell [Cell]
   753   C1515981:And [Idea or Concept]
   753   C1522408:Layer [Qualitative Concept]
   753   C1561599:Layer [Intellectual Product]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   748   C0221923:Granular Layer [Tissue]

Phrase: "as well as"

Phrase: "Purkinje cells of cerebellum"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0034143:Purkinje Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.146: Quantitative analyses in temporal cortex, thalamus, granule cell layer of cerebellum and CA2 and CA3 of hippocampus revealed that tau mRNA levels were similar in Igf1/ and WT brains (data not shown). 

Phrase: "Quantitative analyses in temporal cortex,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0002778:Analysis [Laboratory Procedure]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]

Phrase: "thalamus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039729:Thalamus [Body Part, Organ, or Organ Component]
  1000   C1269896:Thalamus [Body Part, Organ, or Organ Component]

Phrase: "granule cell layer of cerebellum"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C1283325:Layer of cerebellum [Body Part, Organ, or Organ Component]
   762   C0221923:Granular Layer [Tissue]
   760   C0934502:Layer [Body Part, Organ, or Organ Component]
   760   C1522408:Layer [Qualitative Concept]
   760   C1561599:Layer [Intellectual Product]

Phrase: "and"

Phrase: "CA2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "CA3 of hippocampus"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that tau mRNA levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "similar in Igf1/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "WT brains"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.147: View larger version (96K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(96K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.148: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.149: Tau gene expression was examined by in situ hybridization in Igf1/ (A and C) and WT aging brains (B and D). 

Phrase: "Tau gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0017262:Gene Expression [Genetic Function]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "examined by in situ hybridization"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   806   C0444498:In situ [Spatial Concept]
   760   C0020202:Hybridisation [Genetic Function]
   760   C0332128:Examined [Finding]
   760   C1300517:Hybridization [Laboratory Procedure]

Phrase: "in Igf1/"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0202220:IGF1 [Laboratory Procedure]
  1000   C1334089:IGF I [Gene or Genome]
  1000   C1708414:IGFI [Gene or Genome]

Phrase: "(A"

Phrase: "and"

Phrase: "C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "WT aging brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0006104:Brains [Body Part, Organ, or Organ Component]
   779 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.150: Representative dark-field micrographs show tau mRNA hybrid signal as pink silver grains concentrated in the dentate gyrus (DG) and Ammons horn (AH) of hippocampal formation (A and B) and in the granule cell layer as well as Purkinje cells (arrows) of cerebellum (C and D). 

Phrase: "Representative dark-field micrographs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   706   C0240341:Micrographia [Finding]
   706   C0596928:micrography [Laboratory Procedure]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "tau mRNA hybrid signal as pink silver grains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1710082:Signal [Phenomenon or Process]

Phrase: "concentrated in the dentate gyrus (DG)"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0152314:Dentate Gyrus [Body Part, Organ, or Organ Component]
   806   C1281026:Dentate gyrus [Body Part, Organ, or Organ Component]
   760   C1880165:Concentrated [Biomedical or Dental Material]
   726 E C1880310:Concentrate [Manufactured Object]
   726 E C2003864:Concentrate [Substance]

Phrase: "and"

Phrase: "Ammons horn (AH) of hippocampal formation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0019564:Ammons Horn [Body Part, Organ, or Organ Component]
   760   C0019939:Horn [Body Part, Organ, or Organ Component]

Phrase: "(A"

Phrase: "and"

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and in the granule cell layer"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   790   C0596630:granule cell [Cell]
   783 E C0010837:Cell granule [Cell Component]
           Granule
   753   C0007634:Cell [Cell]
   753   C0934502:Layer [Body Part, Organ, or Organ Component]
   753   C0993609:Granule [Biomedical or Dental Material]
   753   C1269647:Cell [Cell]
   753   C1515981:And [Idea or Concept]
   753   C1522408:Layer [Qualitative Concept]
   753   C1561599:Layer [Intellectual Product]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   748   C0221923:Granular Layer [Tissue]

Phrase: "as well as"

Phrase: "Purkinje cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0034143:Purkinje Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: ")"

Phrase: "of cerebellum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "(C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.151: There was no apparent difference in brain tau mRNA levels between two groups.   

Phrase: "There"

Phrase: "was"

Phrase: "no apparent difference in brain tau mRNA levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]

Phrase: "between two groups."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
Processing 00000000.tx.152: Discussion Top Abstract Introduction Materials and Methods Results Discussion References  This study investigated the effects of IGF-I deletion on concomitants of brain aging, namely accumulation of oxidation by-products and tau phosphorylation. 

Phrase: "Discussion Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the effects of IGF-I deletion"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "on concomitants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0521115:Concomitant [Temporal Concept]

Phrase: "of brain aging,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0001811:Ageing [Organism Function]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827 E C0001779:Age [Organism Attribute]

Phrase: "namely accumulation of oxidation by-products"

Phrase: "and"

Phrase: "tau phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.153: We found that aged Igf1/ brains have similar levels of nitrotyrosine residues and lipofuscin deposition compared with WT brains. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that aged Igf1/ brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "have"

Phrase: "similar levels of nitrotyrosine residues"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "lipofuscin deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposition [Functional Concept]

Phrase: "compared with WT brains."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0006104:Brains [Body Part, Organ, or Organ Component]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1707455:Compared [Activity]
   726 E C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.154: We found no difference in levels of enzymes involved in oxidative stress, such as NOS and SOD1, in Igf1/ and WT control brains. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no difference in levels of enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "involved in oxidative stress,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0038435:Stress [Finding]
   770   C0311404:Oxidative [Functional Concept]
   770   C1314939:Involved [Functional Concept]

Phrase: "such as NOS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   901   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0030015:oxide [Inorganic Chemical]
   827   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "and"

Phrase: "SOD1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1151619:SOD-1 [Molecular Function]
  1000   C1420306:SOD1 [Gene or Genome]

Phrase: "in Igf1/"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0202220:IGF1 [Laboratory Procedure]
  1000   C1334089:IGF I [Gene or Genome]
  1000   C1708414:IGFI [Gene or Genome]

Phrase: "and"

Phrase: "WT control brains."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0006104:Brains [Body Part, Organ, or Organ Component]
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]
   779 E C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.155: These observations suggest that IGF-I normally has little effect on oxidative damage during brain aging. 

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that IGF-I normally"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1334089:IGF I [Gene or Genome]
   827   C0021966:I- [Inorganic Chemical]
   827   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "has"

Phrase: "little effect on oxidative damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "during brain aging."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0001811:Ageing [Organism Function]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827 E C0001779:Age [Organism Attribute]
Processing 00000000.tx.156: However, we found that the microtubule-associated protein tau is much more highly phosphorylated in the Igf1 null brain, suggesting that IGF-I normally prevents tau hyperphosphorylation in the brain. 

Phrase: "However,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the microtubule-associated protein tau"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1446659:MICROTUBULE-ASSOCIATED PROTEIN TAU [Gene or Genome]
  1000   C2700455:Microtubule-Associated Protein Tau [Amino Acid, Peptide, or Protein]
   923   C0026045:Microtubule-associated protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0085401:Microtubule protein tau [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1421563:protein tau [Gene or Genome]
   812   C0026046:Micro-tubule [Cell Component]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332281:Associated [Qualitative Concept]
   812   C1720655:Tau [Intellectual Product]
   812   C1947974:Tau [Research Activity]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]

Phrase: "is"

Phrase: "much more highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205250:Highly [Qualitative Concept]

Phrase: "phosphorylated in the Igf1 null brain,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0202220:IGF1 [Laboratory Procedure]
   753   C0456148:Null [Quantitative Concept]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   753   C1334089:IGF I [Gene or Genome]
   753   C1708414:IGFI [Gene or Genome]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that IGF-I normally"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1334089:IGF I [Gene or Genome]
   827   C0021966:I- [Inorganic Chemical]
   827   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "tau hyperphosphorylation in the brain."
Processing 00000000.tx.157: In healthy neurons, tau proteins regulate microtubule function in the nerve processes. 

Phrase: "In healthy neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "tau proteins"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0085401:tau Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "regulate"

Phrase: "microtubule function in the nerve processes."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0700630:neural function [Physiologic Function]
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]
Processing 00000000.tx.158: Hyperphosphorylation dislodges tau from the microtubule surface, resulting in the accumulation of insoluble, toxic tau peptides and compromised axonal integrity (16, 17). 

Phrase: "Hyperphosphorylation"

Phrase: "dislodges"

Phrase: "tau from the microtubule surface,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]

Phrase: "resulting in the accumulation of insoluble, toxic tau peptides"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   764   C0332294:Resulting in [Functional Concept]
   742   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   742   C0600688:toxic [Injury or Poisoning]
   742   C0678226:resulting [Functional Concept]
   742   C1407029:Toxic [Qualitative Concept]
   742   C1720655:Tau [Intellectual Product]
   742   C1947974:Tau [Research Activity]
   708 E C1274040:Result [Functional Concept]
   708 E C1546471:Result [Idea or Concept]
   708 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "compromised axonal integrity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205266:integrity [Qualitative Concept]
   827   C0872403:integrity [Individual Behavior]
   827   C1947912:Integrity [Qualitative Concept]

Phrase: "(16,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.159: In the brains of individuals with Alzheimers disease (AD) and other neurodegenerative diseases, hyperphosphorylated tau is aggregated into intraneuronal deposits or NFTs (17). 

Phrase: "In the brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "with Alzheimers disease (AD)"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "other neurodegenerative diseases,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "hyperphosphorylated tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "aggregated into intraneuronal deposits"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0332621:Aggregated [Functional Concept]
   770   C0333562:Deposits [Functional Concept]
   737 E C0205418:Aggregate [Qualitative Concept]

Phrase: "or"

Phrase: "NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.160: Analysis of tau protein from AD brains by mass spectrometry and sequencing revealed several persistently phosphorylated sites that are recognized by tau-directed antibodies, including tau-1 site (residues 191225), carboxyl-terminal portion of the protein (residues 386438) and Ser 262 (the numbering referred to the longest human tau isoform) (27, 28). 

Phrase: "Analysis of tau protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1514534:Protein Analysis [Molecular Biology Research Technique]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "from AD brains"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C0002395:Alzheimers disease [Disease or Syndrome]

Phrase: "by mass spectrometry"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "sequencing revealed several persistently phosphorylated sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   799   C0205145:Sites [Spatial Concept]
   766 E C1515974:Site [Body Location or Region]
   766 E C2825164:Site [Spatial Concept]

Phrase: "that"

Phrase: "are"

Phrase: "recognized by tau-directed antibodies,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "tau-1 site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
   734   C0250875:tau-1 [Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]

Phrase: "(residues 191225"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "carboxyl-terminal portion of the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449719:Portion [Spatial Concept]

Phrase: "(residues 386438"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "Ser 262"

Phrase: "("

Phrase: "the numbering"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449788:numbering [Quantitative Concept]
   966 E C0237753:*Number [Quantitative Concept]

Phrase: "referred to the longest human tau isoform"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   778   C1555599:Referred to [Idea or Concept]
   778   C1691010:Referred to [Functional Concept]
           Referred
   748   C0086418:Human [Human]
   748   C0205543:referred [Functional Concept]
   748   C0597298:Isoform [Amino Acid, Peptide, or Protein]
   748   C1522425:Longest [Qualitative Concept]
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]
   714 E C0205166:Long [Qualitative Concept]
   714 E C1706317:Long [Qualitative Concept]

Phrase: ")"

Phrase: "(27,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.161: In this report, we demonstrated the Ser-396, adjacent to microtubule-binding domain, and Ser-202, inside the tau-1 antibody binding site, are highly phosphorylated in the IGF-I null brain. 

Phrase: "In this report,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "demonstrated"

Phrase: "the Ser-396,"

Phrase: "adjacent to microtubule-binding domain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0205117:Adjacent to [Spatial Concept]
           Adjacent

Phrase: "and"

Phrase: "Ser-202,"

Phrase: "inside the tau-1 antibody binding site,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   884   C0005457:Antibody binding site [Immunologic Factor,Receptor]
   840   C0005456:Binding Site [Receptor]
   840   C0682969:Binding Site [Amino Acid Sequence]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C0205145:Site [Spatial Concept]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1515974:Site [Body Location or Region]
   804   C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "phosphorylated in the IGF-I null brain."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1334089:IGF I [Gene or Genome]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0021966:I- [Inorganic Chemical]
   748   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0456148:Null [Quantitative Concept]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.162: Both sites are implicated in NFT formation. 

Phrase: "Both sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "implicated in NFT formation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0085400:NFT [Acquired Abnormality]
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]
Processing 00000000.tx.163: However, Ser-262 phosphorylation site was not altered by IGF-I deletion. 

Phrase: "However,"

Phrase: "Ser-262 phosphorylation site"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1519063:Phosphorylation Site [Amino Acid Sequence]
   812   C0031715:Phosphorylation [Molecular Function]
   812   C0205145:Site [Spatial Concept]
   812   C1158886:Phosphorylation [Molecular Function]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "altered by IGF-I deletion."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1334089:IGF I [Gene or Genome]
   760   C0021966:I- [Inorganic Chemical]
   760   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0392747:Altered [Functional Concept]
   760   C1442161:Deletion [Cell or Molecular Dysfunction]
   760   C1511760:Deletion [Genetic Function]
   760   C1880274:Deletion [Activity]
Processing 00000000.tx.164: Moreover, IGF-I deletion is not associated with reduced tau mRNA or protein levels. 

Phrase: "Moreover,"

Phrase: "IGF-I deletion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1442161:Deletion [Cell or Molecular Dysfunction]
   827   C1511760:Deletion [Genetic Function]
   827   C1880274:Deletion [Activity]
   734   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1334089:IGF I [Gene or Genome]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated with reduced tau mRNA"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0392756:Reduced [Qualitative Concept]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "or"

Phrase: "protein levels."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C0428479:Protein level [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.165: These observations suggest that IGF-I regulates tau phosphorylation on specific phosphorylation sites in the brain, but does not have a general effect on tau synthesis. 

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that IGF-I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:IGF I [Gene or Genome]
   861   C0021966:I- [Inorganic Chemical]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "regulates"

Phrase: "tau phosphorylation on specific phosphorylation sites"

Phrase: "in the brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "but"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "a general effect on tau synthesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.166: Tau-directed protein kinases may be divided into three groups: 1) second-messenger-activated kinases, including protein kinase C, protein kinase A, and Ca2+/calmodulin-dependent kinase; 

Phrase: "Tau-directed protein kinases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   906   C0215619:tau-protein kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   861   C0033640:Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "be"

Phrase: "divided into three groups"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0205449:Three [Quantitative Concept]
   770   C0332849:Divided [Functional Concept]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "second-messenger-activated kinases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "protein kinase C,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "protein kinase A,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Ca2+/calmodulin-dependent kinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0006776:Calmodulin-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.167: 2) Ser/Pro-directed kinases, including MAPK, cyclin-dependent kinase 5, cell division cycle 2, GSK3, GSK3, and PAR-1 (29); 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "Ser/Pro-directed kinases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "MAPK,"

Phrase: "cyclin-dependent kinase 5,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0249586:Cyclin-Dependent Kinase 5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CYCLIN-DEPENDENT KINASE 5 [Gene or Genome]
   923   C0243045:Cyclin-Dependent Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1150565:cyclin [Molecular Function]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]

Phrase: "cell division cycle 2,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C0080054:Cell Division Cycle 2 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0007586:Cell Division Cycle [Cell Function]
           Cell Cycle
   875   C1155839:Cell Cycle [Cell Function]
   861   C0007590:Cell division [Cell Function]
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1293097:Division [Therapeutic or Preventive Procedure]
   812   C1511572:Cycle [Temporal Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   812   C2919030:Division [Organization]
   812   C2919031:Division [Activity]

Phrase: "GSK3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "GSK3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "PAR-1 (29"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1366449:PAR-1 [Gene or Genome]
   901   C1414387:PAR-1 [Gene or Genome]
   827   C1417826:PAR [Gene or Genome]
   827   C1514229:PAR [Quantitative Concept]
   827   C1705885:PAR [Gene or Genome]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.168: and 3) other kinases, including p110mapk and casein kinase (for review see Ref.30). 

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "other kinases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "p110mapk"

Phrase: "and"

Phrase: "casein kinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0054846:casein kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0007332:Casein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "("

Phrase: "for review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Ref.30"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.169: These different kinases phosphorylate tau at various specific as well as overlapping sites (30), as for which kinases are most critical for AD-type NFT formation still under active debate. 

Phrase: "These different kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "phosphorylate"

Phrase: "tau at various specific"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]

Phrase: "as well as"

Phrase: "overlapping sites"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0456206:Overlapping sites [Spatial Concept]
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "(30"

Phrase: ")"

Phrase: ","

Phrase: "as for which kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "most critical for AD-type NFT formation still under active debate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C1511545:Critical [Qualitative Concept]
Processing 00000000.tx.170: The present study illuminates the role of GSK3 in tau phosphorylation in vivo because IGF-I inhibits this kinase activity and specific GSK3 targets sites, Ser202 and Ser-396, are hyperphosphorylated in the IGF-I null brain. 

Phrase: "The present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "illuminates"

Phrase: "the role of GSK3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in tau phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "because"

Phrase: "IGF-I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:IGF I [Gene or Genome]
   861   C0021966:I- [Inorganic Chemical]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "this kinase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150423:kinase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "specific GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "targets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "sites,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "Ser202"

Phrase: "and"

Phrase: "Ser-396,"

Phrase: "are"

Phrase: "hyperphosphorylated in the IGF-I null brain."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1334089:IGF I [Gene or Genome]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0021966:I- [Inorganic Chemical]
   748   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0456148:Null [Quantitative Concept]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.171: These GSK3 phosphoryated sites were well documented in in vitro studies (30, 31, 32, 33). 

Phrase: "These GSK3 phosphoryated sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "were"

Phrase: "well documented in in vitro studies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0205170:Well [Qualitative Concept]
   753   C1301725:Documented [Health Care Activity]
   753   C1609436:documented [Idea or Concept]
   753   C3146287:Well [Manufactured Object]
   719 E C1301746:document [Intellectual Product]
   719 E C1547673:Document [Intellectual Product]

Phrase: "(30,"

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32,"

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.172: It is also well known that activation of IGF-I/insulin receptors triggers activation of the serine/threonine protein kinase Akt (34), which phosphorylates GSK-3 ser9, resulting in its inhibition (35). 

Phrase: "It"

Phrase: "is"

Phrase: "also well known"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205170:Well [Qualitative Concept]
   827   C0205309:Known [Qualitative Concept]
   827   C3146287:Well [Manufactured Object]

Phrase: "that activation of IGF-I/insulin receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1514758:Receptor Activation [Cell Function]
   748   C1879547:Activation [Activity]

Phrase: "triggers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "activation of the serine/threonine protein kinase Akt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1819041:protein kinase activation [Cell Function]
   767   C0599177:protein activation [Genetic Function]
   744   C1879547:Activation [Activity]

Phrase: "(34"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "phosphorylates"

Phrase: "GSK-3 ser9,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "resulting in its inhibition"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0332294:Resulting in [Functional Concept]
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C0678226:resulting [Functional Concept]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.173: We have previously shown that both GSK-3 and Akt phosphorylation are significantly reduced in the Igf1 null brain compared with WT (36), suggesting that overactive GSK-3 may cause tau hyperphosphorylation in the Igf1 null brain. 

Phrase: "We"

Phrase: "have"

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "both GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "Akt phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "are"

Phrase: "significantly"

Phrase: "reduced in the Igf1 null brain"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0202220:IGF1 [Laboratory Procedure]
   753   C0392756:Reduced [Qualitative Concept]
   753   C0456148:Null [Quantitative Concept]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   753   C1334089:IGF I [Gene or Genome]
   753   C1708414:IGFI [Gene or Genome]

Phrase: "compared with WT"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1547052:*Type [Quantitative Concept]
   770   C1707455:Compared [Activity]

Phrase: "(36"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that overactive GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "tau hyperphosphorylation in the Igf1 null brain."
Processing 00000000.tx.174: All of these data indicate that disturbance in IGF-I signaling cascade leads to aberrant tau hyperphosphorylation, potentiating the formation of NFT. 

Phrase: "All of these data"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0444868:All [Quantitative Concept]
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]
   770   C3539085:All [Idea or Concept]

Phrase: "indicate"

Phrase: "that disturbance in IGF-I signaling cascade"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2699787:Disturbance [Qualitative Concept]

Phrase: "leads to aberrant tau hyperphosphorylation,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0181586:leads [Medical Device]
   760   C0443127:Aberrant [Qualitative Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "potentiating"

Phrase: "the formation of NFT."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]
Processing 00000000.tx.175: GSK3s contribution to tau-mediated neurodegeneration is unsettled; 

Phrase: "GSK3s contribution to tau-mediated neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880177:Contribution [Activity]

Phrase: "is"

Phrase: "unsettled"

Phrase: ";"
Processing 00000000.tx.176: GSK3 overexpression was associated with tau hyperphosphorylation and neurodegeneration in some studies (37, 38, 39) but was associated with reduced neurodegeneration in a different murine model (40). 

Phrase: "GSK3 overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514559:Overexpression [Genetic Function]

Phrase: "was"

Phrase: "associated with tau hyperphosphorylation"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "neurodegeneration in some studies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "(37,"

Phrase: "38,"

Phrase: "39"

Phrase: ")"

Phrase: "but"

Phrase: "was"

Phrase: "associated with reduced neurodegeneration"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
   770   C0392756:Reduced [Qualitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in a different murine model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Model [Intellectual Product]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.177: This latter study in a complex, multiple transgenic model, found that although more hyperphosphorylated tau was present, neither an increase in insoluble tau aggregates nor the presence of paired helical filaments or tangles was observed. 

Phrase: "This latter study in a complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]

Phrase: "multiple transgenic model,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1519606:Transgenic Model [Experimental Model of Disease]
   827   C3161035:Model [Intellectual Product]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "although"

Phrase: "more hyperphosphorylated tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "was"

Phrase: "present,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "neither an increase in insoluble tau aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "nor"

Phrase: "the presence of paired helical filaments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "tangles"

Phrase: "was"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.178: However, in human brains NFTs invariably contain tau phosphorylated on GSK3 target sites and GSK3 is consistently found colocalized with pretangle and tangle-bearing neurons (41). 

Phrase: "However,"

Phrase: "in human brains NFTs invariably"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   840   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   806 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "phosphorylated on GSK3 target sites"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0205145:Sites [Spatial Concept]
   760   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1521840:Target [Functional Concept]
   760   C2986546:TARGET [Diagnostic Procedure]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "consistently"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "colocalized with pretangle"

Phrase: "and"

Phrase: "tangle-bearing neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.179: The mouse brain does not normally exhibit the neuropathological hallmarks of human brain aging and neurodegenerative disorders such as amyloid plaques or NFTs (42), and we did not detect such abnormal markers in either Igf1 null or WT brain in this study. 

Phrase: "The mouse brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1521713:Mouse Brain [Tissue]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "does"

Phrase: "not normally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "the neuropathological hallmarks of human brain aging"

Phrase: "and"

Phrase: "neurodegenerative disorders such as amyloid plaques"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
   790   C1522560:Neurodegenerative Disorders [Functional Concept]
   753   C0012634:Disorders [Disease or Syndrome]

Phrase: "or"

Phrase: "NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "(42"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "we"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "such abnormal markers in either Igf1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0005516:Marker [Clinical Attribute]

Phrase: "null"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456148:Null [Quantitative Concept]

Phrase: "or"

Phrase: "WT brain in this study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.180: However, the present study provides an important in vivo loss-of-function model illustrating a role for IGF-I in regulation of tau phosphorylation by inhibition of GSK3, potentially impacting tau-mediated neurodegeneration in the mature/aging murine brain. 

Phrase: "However,"

Phrase: "the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "an important in vivo loss-of-function model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1515657:In Vivo Model [Research Activity]
   795   C3161035:Model [Intellectual Product]

Phrase: "illustrating"

Phrase: "a role for IGF-I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of tau phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "by inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of GSK3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "potentially"

Phrase: "impacting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1825598:IMPACT [Gene or Genome]

Phrase: "tau-mediated neurodegeneration in the mature/aging murine brain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.181: This may be a somewhat more physiological model than previous studies based on GSK3 overexpression in cell culture or transgenic animals for its link to tau hyperphosphorylation (33, 37, 43). 

Phrase: "This"

Phrase: "may"

Phrase: "be"

Phrase: "a somewhat more physiological model than previous studies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C3161035:Model [Intellectual Product]

Phrase: "based on GSK3 overexpression in cell culture"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   778   C0007585:Cell Culture [Laboratory Procedure]
   748   C0007634:Cell [Cell]
   748   C0010453:Culture [Idea or Concept]
   748   C0220814:culture [Functional Concept]
   748   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0430400:Culture [Laboratory Procedure]
   748   C1269647:Cell [Cell]
   748   C1514559:Overexpression [Genetic Function]
   748   C1527178:Based [Functional Concept]
   748   C1704653:Cell [Medical Device]
   748   C1705938:Based [Idea or Concept]
   748   C1948049:Cell [Spatial Concept]
   748   C2242979:Culture [Laboratory Procedure]
   714 E C0002055:base [Inorganic Chemical]
   714 E C0178499:Base [Chemical Viewed Functionally]
   714 E C1880279:Base [Biomedical or Dental Material]

Phrase: "or"

Phrase: "transgenic animals for its link"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0003069:Animals, Transgenic [Animal]
   760   C0003062:Animals [Animal]

Phrase: "to tau hyperphosphorylation"

Phrase: "(33,"

Phrase: "37,"

Phrase: "43"

Phrase: ")."
Processing 00000000.tx.182: This study found similar levels of SOD and NOS enzymes, and similar markers of oxidative damage in Igf1/ and WT brains, except for a small increase in nitrotyrosine residues detected in cortical layer IV/V in the Igf1null mouse. 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "similar levels of SOD"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "NOS enzymes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0014442:Enzymes [Enzyme,Organic Chemical]
   812   C0014445:enzymes [Functional Concept]
   756   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "similar markers of oxidative damage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0005516:Marker [Clinical Attribute]

Phrase: "in Igf1/"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0202220:IGF1 [Laboratory Procedure]
  1000   C1334089:IGF I [Gene or Genome]
  1000   C1708414:IGFI [Gene or Genome]

Phrase: "and"

Phrase: "WT brains,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "except for a small increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "in nitrotyrosine residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "detected in cortical layer IV/V"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0001613:Cortical [Body Part, Organ, or Organ Component]
   753   C0007776:Cortical [Body Part, Organ, or Organ Component]
   753   C0022655:Cortical [Body Part, Organ, or Organ Component]
   753   C0442726:Detected [Finding]
   753   C0934502:Layer [Body Part, Organ, or Organ Component]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1522408:Layer [Qualitative Concept]
   753   C1561599:Layer [Intellectual Product]

Phrase: "in the Igf1null mouse."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]
Processing 00000000.tx.183: This could mean that IGF-I does not normally have a major role in mature brain oxidative activity or antioxidant defenses. 

Phrase: "This"

Phrase: "could"

Phrase: "mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "that IGF-I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:IGF I [Gene or Genome]
   861   C0021966:I- [Inorganic Chemical]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "does"

Phrase: "not normally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "a major role in mature brain oxidative activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "or"

Phrase: "antioxidant defenses."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003402:Antioxidant [Pharmacologic Substance]
   861   C1880266:Defense [Conceptual Entity]
Processing 00000000.tx.184: However, lipofuscin and NT residues are relatively nonspecific markers of neuronal oxidative activity, and it remains possible that IGF-I is active in specific metabolic pathways we have not detected with this methodology. 

Phrase: "However,"

Phrase: "lipofuscin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023789:Lipofuscin [Biologically Active Substance,Lipid]

Phrase: "and"

Phrase: "NT residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "are"

Phrase: "relatively nonspecific markers of neuronal oxidative activity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0005516:Marker [Clinical Attribute]

Phrase: "and"

Phrase: "it"

Phrase: "remains"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that IGF-I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:IGF I [Gene or Genome]
   861   C0021966:I- [Inorganic Chemical]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "active in specific metabolic pathways"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205177:Active [Functional Concept]

Phrase: "we"

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected with this methodology."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0442726:Detected [Finding]
   770   C0969625:methodology [Intellectual Product]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C3266812:Methodology [Idea or Concept]
Processing 00000000.tx.185: IGF-I and/or insulin have been implicated in other aspects of neurodegenerative disease (12, 44). 

Phrase: "IGF-I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:IGF I [Gene or Genome]
   861   C0021966:I- [Inorganic Chemical]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and/or"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "have"

Phrase: "been"

Phrase: "implicated in other aspects of neurodegenerative disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0524851:Neurodegenerative Disease [Disease or Syndrome]
   748   C0012634:Disease [Disease or Syndrome]
   714   C1547011:Aspect [Quantitative Concept]
   714   C1879746:Aspect [Qualitative Concept]

Phrase: "(12,"

Phrase: "44"

Phrase: ")."
Processing 00000000.tx.186: The human brain affected by Alzheimer-type deterioration is consistently found to exhibit reduced glucose use (45, 46). 

Phrase: "The human brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "affected by Alzheimer-type deterioration"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0332307:Type [Qualitative Concept]
   760   C0392760:Affected [Functional Concept]
   760   C0868945:Deterioration [Phenomenon or Process]
   760   C1314939:Affected [Functional Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0001721:Affect [Mental Process]

Phrase: "is"

Phrase: "consistently"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "reduced glucose use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0042153:use [Functional Concept]
   827   C0457083:Use [Functional Concept]
   827   C1947944:Use [Intellectual Product]

Phrase: "(45,"

Phrase: "46"

Phrase: ")."
Processing 00000000.tx.187: We have previously shown a highly significant positive correlation between local IGF-I expression and brain glucose use in the maturing mouse brain (36), suggesting that reduction in local or perhaps circulating IGF-I levels may contribute to reduced glucose metabolism and cerebral dysfunction in the adult. 

Phrase: "We"

Phrase: "have"

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a highly significant positive correlation between local IGF-I expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "brain glucose use in the maturing mouse brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0042153:use [Functional Concept]
   744   C0457083:Use [Functional Concept]
   744   C1947944:Use [Intellectual Product]

Phrase: "(36"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that reduction in local"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "perhaps"

Phrase: "circulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175630:Circulating [Functional Concept]

Phrase: "IGF-I levels"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0441925:i levels [Intellectual Product]
   901   C1334089:IGF I [Gene or Genome]
   827   C0021966:I- [Inorganic Chemical]
   827   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "may"

Phrase: "contribute to reduced glucose metabolism"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0596620:glucose metabolism [Molecular Function]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]
   760   C0392756:Reduced [Qualitative Concept]
   760   C1880177:Contribute [Activity]

Phrase: "and"

Phrase: "cerebral dysfunction in the adult."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0262405:CEREBRAL DYSFUNCTION [Disease or Syndrome]
   760   C0031847:dysfunction [Functional Concept]
   760   C0277785:Dysfunction, NOS [Qualitative Concept]
   704 E C0231174:Malfunction [Functional Concept]
   704 E C1881681:MALFUNCTION [Phenomenon or Process]
Processing 00000000.tx.188: Recently, a potential relation between reduced insulin/IGF-I signaling and -amyloid accumulation has also been suggested (46, 47). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "a potential relation between reduced insulin/IGF-I signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0080103:Relation [Family Group]
   742   C0869014:relation [Social Behavior]

Phrase: "and -"

Phrase: "amyloid accumulation"

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "(46,"

Phrase: "47"

Phrase: ")."
Processing 00000000.tx.189: Therefore, reduced IGF-I/insulin signaling is implicated in several major pathological features of AD, including amyloidosis, NFT, cell demise and aberrant brain glucose use. 

Phrase: "Therefore,"

Phrase: "reduced IGF-I/insulin signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0037083:Signaling [Cell Function]
   804   C3537152:signaling [Biologic Function]

Phrase: "is"

Phrase: "implicated in several major pathological features of AD,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0002395:Alzheimers disease [Disease or Syndrome]
   742   C0012634:Disease [Disease or Syndrome]
   742   C0030664:Pathological [Biomedical Occupation or Discipline]
   742   C0205164:Major [Qualitative Concept]
   742   C1521733:Pathological [Functional Concept]
   708   C1521970:Feature [Qualitative Concept]
   708   C1706388:Feature [Conceptual Entity]
   708   C2346469:Feature [Qualitative Concept]
   708   C2348519:Feature [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "amyloidosis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002726:Amyloidosis [Disease or Syndrome]

Phrase: "NFT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085400:NFT [Acquired Abnormality]

Phrase: "cell demise"

Phrase: "and"

Phrase: "aberrant brain glucose use."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0042153:use [Functional Concept]
   812   C0457083:Use [Functional Concept]
   812   C1947944:Use [Intellectual Product]
Processing 00000000.tx.190: These observations suggest that preventing the age-related decline in circulating (48) and brain IGF-I levels (49, 50) may help reduce the risk of AD.  

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that preventing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the age-related decline in circulating"

Phrase: "(48"

Phrase: ")"

Phrase: "and"

Phrase: "brain IGF-I levels"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441925:i levels [Intellectual Product]
   861   C1334089:IGF I [Gene or Genome]
   812   C0021966:I- [Inorganic Chemical]
   812   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "(49,"

Phrase: "50"

Phrase: ")"

Phrase: "may"

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "reduce"

Phrase: "the risk of AD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.191: Acknowledgments  We thank Dr. 

Phrase: "Acknowledgments"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.192: Shu-Hui Yen at Mayo Clinic for discussion in tau pathologies and Dr. 

Phrase: "Shu-Hui Yen at Mayo Clinic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1555429:Yen [Quantitative Concept]

Phrase: "for discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "in tau pathologies"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0030664:Pathologies [Biomedical Occupation or Discipline]
   827 E C0205469:pathology [Functional Concept]
   827 E C0677042:pathology [Pathologic Function]
   777 E C1521733:Pathologic [Functional Concept]

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.193: Peter Seubert at Elan Pharmaceuticals, Inc. 

Phrase: "Peter Seubert at Elan Pharmaceuticals,"

Phrase: "Inc."
Processing 00000000.tx.194: (San Francisco, CA) for providing the 12E8 antibody.  

Phrase: "(San Francisco,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036152:San Francisco [Geographic Area]
   861   C1826357:San [Gene or Genome]

Phrase: "CA) for providing"

Phrase: "the 12E8 antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.195: Footnotes  First Published Online August 25, 2005 Abbreviations: AD, Alzheimers disease; 

Phrase: "Footnotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825232:Footnote [Intellectual Product]

Phrase: "First"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: "Online August 25,"

Phrase: "2005 Abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0000723:Abbreviations [Intellectual Product]

Phrase: ":"

Phrase: "AD,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.196: GSK, glycogen synthase kinase; 

Phrase: "GSK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1325174:GSK [Molecular Function]

Phrase: "glycogen synthase kinase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.197: iNOS, inducible NOS; 

Phrase: "iNOS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518425:{NOS} [Qualitative Concept]

Phrase: "inducible NOS"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0669372:Nitric Oxide Synthase, Inducible [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417760:NITRIC OXIDE SYNTHASE, INDUCIBLE [Gene or Genome]
  1000   C1533698:Inducible Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: ";"
Processing 00000000.tx.198: NFTs, neurofibrillary tangles; 

Phrase: "NFTs,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: ";"
Processing 00000000.tx.199: NOS, nitric oxide synthase; 

Phrase: "NOS,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   901   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0030015:oxide [Inorganic Chemical]
   827   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "nitric oxide synthase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   901   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0030015:oxide [Inorganic Chemical]
   827   C2986642:oxide [Chemical Viewed Functionally]

Phrase: ";"
Processing 00000000.tx.200: nNOS, neuronal NOS; 

Phrase: "nNOS,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0521390:Neuronal [Immunologic Factor]
   861   C1518425:{NOS} [Qualitative Concept]
   789 E C0027882:Neuron [Cell]

Phrase: "neuronal NOS"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0669368:Neuronal Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907533:Neuronal Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0030015:oxide [Inorganic Chemical]
   812   C0521390:Neuronal [Immunologic Factor]
   812   C2986642:oxide [Chemical Viewed Functionally]
   741 E C0027882:Neuron [Cell]

Phrase: ";"
Processing 00000000.tx.201: PHF, paired helical filaments; 

Phrase: "PHF,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   890   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   812   C1709450:Paired [Qualitative Concept]
   779   C0010851:Filament [Cell Component]
   729 E C1979891:Filamentous [Qualitative Concept]

Phrase: "paired helical filaments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   827   C1709450:Paired [Qualitative Concept]
   793   C0010851:Filament [Cell Component]
   743 E C1979891:Filamentous [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.202: SOD, superoxide dismutase; 

Phrase: "SOD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038838:Superoxide Dismutase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0038836:Superoxide [Element, Ion, or Isotope]

Phrase: "superoxide dismutase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038838:Superoxide Dismutase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0038836:Superoxide [Element, Ion, or Isotope]

Phrase: ";"
Processing 00000000.tx.203: WT, wild type. 

Phrase: "WT, wild type."
Processing 00000000.tx.204: Received January 18, 2005. 

Phrase: "Received January 18,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514756:Received [Qualitative Concept]

Phrase: "2005."
Processing 00000000.tx.205: Accepted for publication August 15, 2005.  

Phrase: "Accepted for publication August 15,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1272684:Accepted [Qualitative Concept]
   760   C1548435:Accepted [Idea or Concept]
   760   C1704324:Publication [Intellectual Product]
   726 E C1548601:Accept [Idea or Concept]

Phrase: "2005."
Processing 00000000.tx.206: References Top Abstract Introduction Materials and Methods Results Discussion References  Clancy DJ, Gems D, Harshman LG, Oldham S, Stocker H, Hafen E, Leevers SJ, Partridge L 2001 Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Clancy DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Gems D,"

Phrase: "Harshman LG,"

Phrase: "Oldham S,"

Phrase: "Stocker H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Hafen E,"

Phrase: "Leevers SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Partridge L 2001 Extension of life-span"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0162402:Life Extension [Human-caused Phenomenon or Process]
   748   C0231448:Extension [Functional Concept]
   748   C1880641:Extension [Conceptual Entity]

Phrase: "by loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517945:Loss [Quantitative Concept]

Phrase: "of CHICO,"

Phrase: "a Drosophila insulin receptor substrate protein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   897   C0949989:Drosophila Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   853   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.207: Science 292:104106[Abstract/Free FullText] Wolkow CA, Kimura KD, Lee MS, Ruvkun G 2000 Regulation of C. elegans life-span by insulinlike signaling in the nervous system. 

Phrase: "Science 292"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "104106"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wolkow CA,"

Phrase: "Kimura KD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0026691:KD [Disease or Syndrome]
   861   C1705240:KD [Gene or Genome]
   861   C1839259:KD [Disease or Syndrome]

Phrase: "Lee MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "Ruvkun G 2000 Regulation of C. elegans life-span"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1327622:Regulation [Biologic Function]

Phrase: "by insulinlike signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "in the nervous system."
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0027763:Nervous System [Body System]
  1000   C0422837:NERVOUS SYSTEM [Finding]
  1000   C1269560:Nervous system [Body System]
   944 E C0205494:Neurologic [Qualitative Concept]
   907 E C0027855:Neurology [Biomedical Occupation or Discipline]
   888 E C2707261:Neurological [Clinical Attribute]
   861   C0027769:Nervous [Sign or Symptom]
   861   C0449913:System [Functional Concept]
   861   C0599851:Nervous [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]
   745 E C0027740:Nerve [Tissue]
   745 E C0027757:NERVE [Tissue]
   745 E C1280541:Nerve [Body Part, Organ, or Organ Component]
Processing 00000000.tx.208: Science 290:147150[Abstract/Free FullText] Brown-Borg HM, Borg KE, Meliska CJ, Bartke A 1996 Dwarf mice and the ageing process. 

Phrase: "Science 290"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "147150"

Phrase: "[Abstract/Free FullText"

Phrase: "] Brown-Borg HM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0262500:hm [Health Care Activity]
   827   C1512358:HM [Geographic Area]
   827   C3538713:HM [Idea or Concept]

Phrase: "Borg KE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022558:KE [Geographic Area]

Phrase: "Meliska CJ,"

Phrase: "Bartke"

Phrase: "A 1996 Dwarf mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "the ageing process."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1510835:Aging Process [Organism Function]
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.209: Nature 384:33[Medline] Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang R 1993 A C. elegans mutant that lives twice as long as wild type. 

Phrase: "Nature 384"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "33"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kenyon C,"

Phrase: "Chang J,"

Phrase: "Gensch E,"

Phrase: "Rudner A,"

Phrase: "Tabtiang R 1993 A C. elegans mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "lives"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0595998:lives [Finding]
  1000   C1548795:Live [Qualitative Concept]
  1000   C1634625:% live [Qualitative Concept]
  1000   C2982691:Live [Activity]

Phrase: "twice as long"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205166:Long [Qualitative Concept]
   790   C1706317:Long [Qualitative Concept]
   790   C1720725:Twice [Intellectual Product]
   790   C1948050:Twice [Quantitative Concept]

Phrase: "as wild type."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.210: Nature 366:461464[CrossRef][Medline] Tatar M, Kopelman A, Epstein D, Tu MP, Yin CM, Garofalo RS 2001 A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. 

Phrase: "Nature 366"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "461464"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tatar M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kopelman A,"

Phrase: "Epstein D,"

Phrase: "Tu MP,"

Phrase: "Yin CM,"

Phrase: "Garofalo RS 2001"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3539879:RS [Idea or Concept]

Phrase: "A mutant Drosophila insulin receptor homolog"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C1334043:Homolog [Gene or Genome]
   704 E C2697616:Homology [Qualitative Concept]

Phrase: "that"

Phrase: "extends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "life-span"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0870809:life span [Group Attribute]
   861   C0376558:Life [Idea or Concept]
   861   C1711300:Span [Conceptual Entity]
   861   C2700613:Span [Quantitative Concept]
   777 E C0595998:lives [Finding]

Phrase: "and"

Phrase: "impairs"

Phrase: "neuroendocrine function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.211: Science 292:107110[Abstract/Free FullText] Holzenberger M, Dupont J, Ducos B, Leneuve P, Geloen A, Even PC, Cervera P, Le Bouc Y 2003 IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. 

Phrase: "Science 292"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "107110"

Phrase: "[Abstract/Free FullText"

Phrase: "] Holzenberger M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Dupont J,"

Phrase: "Ducos B,"

Phrase: "Leneuve P,"

Phrase: "Geloen A,"

Phrase: "Even PC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: "Cervera P,"

Phrase: "Le Bouc Y 2003 IGF-1 receptor"
Meta Candidates (Total=23; Excluded=2; Pruned=0; Remaining=21)
   884   C0140080:Insulin-Like Growth Factor 1 Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   884   C1334088:insulin-like growth factor 1 receptor [Gene or Genome]
   863   C0140079:Insulin-Like Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   846   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   846   C1334133:INSULIN RECEPTOR [Gene or Genome]
   840   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   840   C1753359:insulin-like growth factor [Molecular Function]
   827   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018270:'growth' NOS [Organism Function]
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0220844:growth [Physiologic Function]
   790   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   790   C1521761:Factor [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   790   C1621966:Growth [Organ or Tissue Function]
   790   C2827422:Factor [Conceptual Entity]
   790   C2911660:Growth [Activity]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "regulates"

Phrase: "lifespan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0870809:life span [Group Attribute]

Phrase: "and"

Phrase: "resistance to oxidative stress"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0332325:Resistant to [Functional Concept]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]

Phrase: "in mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.212: Nature 421:182187[CrossRef][Medline] Russell JW, Sullivan KA, Windebank AJ, Herrmann DN, Feldman EL 1999 Neurons undergo apoptosis in animal and cell culture models of diabetes. 

Phrase: "Nature 421"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "182187"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Russell JW,"

Phrase: "Sullivan KA,"

Phrase: "Windebank AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Herrmann DN,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1333964:DN [Disease or Syndrome]
   861   C1707618:DN [Intellectual Product]

Phrase: "Feldman EL 1999 Neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "undergo"

Phrase: "apoptosis in animal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0162638:Apoptosis [Cell Function]
   718 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "cell culture models of diabetes."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0007585:Cell Culture [Laboratory Procedure]
   760   C0007634:Cell [Cell]
   760   C0010453:Culture [Idea or Concept]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2242979:Culture [Laboratory Procedure]
   760   C3161035:Models [Intellectual Product]
Processing 00000000.tx.213: Neurobiol Dis 6:347363[CrossRef][Medline] Heck S, Lezoualch F, Engert S, Behl C 1999 Insulin-like growth factor-1-mediated neuroprotection against oxidative stress is associated with activation of nuclear factor B. 

Phrase: "Neurobiol Dis 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0451119:DIS [Intellectual Product]
   827   C1444662:DIS [Finding]

Phrase: ":"

Phrase: "347363"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Heck S,"

Phrase: "Lezoualch F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Engert S,"

Phrase: "Behl C 1999 Insulin-like growth factor-1-mediated neuroprotection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0598958:Neuroprotection [Cell Function]

Phrase: "against oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "is"

Phrase: "associated with activation of nuclear factor B."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C1824728:FACTOR B [Gene or Genome]
   748   C0521447:Nuclear [Spatial Concept]
   748   C1521761:Factor [Functional Concept]
   748   C1879547:Activation [Activity]
   748   C2827422:Factor [Conceptual Entity]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.214: J Biol Chem 274:98289835[Abstract/Free FullText] Gustafsson H, Soderdahl T, Jonsson G, Bratteng JO, Forsby A 2004 Insulin-like growth factor type 1 prevents hyperglycemia-induced uncoupling protein 3 down-regulation and oxidative stress. 

Phrase: "J Biol Chem 274"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "98289835"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gustafsson H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Soderdahl T,"

Phrase: "Jonsson G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Bratteng JO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022418:JO [Geographic Area]

Phrase: "Forsby"

Phrase: "A 2004 Insulin-like growth factor type 1"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   911   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   911   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   877   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   877   C1753359:insulin-like growth factor [Molecular Function]
   861   C0457592:Insulin type [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   818   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0441729:Type 1 [Classification]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0220844:growth [Physiologic Function]
   795   C0332307:Type [Qualitative Concept]
   795   C1521761:Factor [Functional Concept]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1547052:*Type [Quantitative Concept]
   795   C1579433:Insulin [Pharmacologic Substance]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C2827422:Factor [Conceptual Entity]
   795   C2911660:Growth [Activity]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "hyperglycemia-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "uncoupling protein 3 down-regulation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0013081:Down-Regulation [Cell Function,Molecular Function]
   804   C0851285:Regulation [Governmental or Regulatory Activity]
   804   C1327622:Regulation [Biologic Function]
   748   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   748   C2626739:Lanugo [Eukaryote]
   717   C0539733:uncoupling protein-3 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C1421315:UNCOUPLING PROTEIN 3 [Gene or Genome]

Phrase: "and"

Phrase: "oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.215: J Neurosci Res 77:285291[CrossRef][Medline] Kaspar BK, Llado J, Sherkat N, Rothstein JD, Gage FH 2003 Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. 

Phrase: "J Neurosci Res 77"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347379:RES [Finding]

Phrase: ":"

Phrase: "285291"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kaspar BK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006100:BK [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C1537501:BK [Gene or Genome]

Phrase: "Llado J,"

Phrase: "Sherkat N,"

Phrase: "Rothstein JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Gage FH 2003 Retrograde viral delivery of IGF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0011209:Delivery [Therapeutic or Preventive Procedure]
   736   C0559563:delivery [Finding]
   736   C1705822:Delivery [Activity]

Phrase: "prolongs"

Phrase: "survival in a mouse ALS model."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0038952:Survival [Activity]
   753   C0220921:survival [Functional Concept]
Processing 00000000.tx.216: Science 301:839842[Abstract/Free FullText] Gasparini L, Xu H 2003 Potential roles of insulin and IGF-1 in Alzheimers disease. 

Phrase: "Science 301"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "839842"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gasparini L,"

Phrase: "Xu H 2003 Potential roles of insulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0035820:Roles [Social Behavior]
   714 E C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "IGF-1 in Alzheimers disease."
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   869   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   869   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   833   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   833   C1753359:insulin-like growth factor [Molecular Function]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0679238:disease factor [Functional Concept]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0220844:growth [Physiologic Function]
   744   C1521761:Factor [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]
   739   C1425075:MALS-1 [Gene or Genome]
Processing 00000000.tx.217: Trends Neurosci 26:404406[CrossRef][Medline] Trejo JL, Carro E, Garcia-Galloway E, Torres-Aleman I 2004 Role of insulin-like growth factor I signaling in neurodegenerative diseases. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci 26"

Phrase: ":"

Phrase: "404406"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Trejo JL,"

Phrase: "Carro E,"

Phrase: "Garcia-Galloway E,"

Phrase: "Torres-Aleman I 2004 Role of insulin-like growth factor I signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0035820:Role [Social Behavior]
   736   C1705810:Role [Conceptual Entity]

Phrase: "in neurodegenerative diseases."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.218: J Mol Med 82:156162[CrossRef][Medline] Terman A, Brunk UT 1998 Lipofuscin: mechanisms of formation and increase with age. 

Phrase: "J Mol Med 82"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C2346604:J/mol [Quantitative Concept]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "156162"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Terman A,"

Phrase: "Brunk UT 1998 Lipofuscin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0023789:Lipofuscin [Biologically Active Substance,Lipid]

Phrase: ":"

Phrase: "mechanisms of formation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0441712:Mechanisms [Functional Concept]
   756 E C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "increase with age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0442805:Increase [Functional Concept]
Processing 00000000.tx.219: APMIS 106:265276[Medline] Fridovich I 1995 Superoxide radical and superoxide dismutases. 

Phrase: "APMIS 106"

Phrase: ":"

Phrase: "265276"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fridovich I 1995 Superoxide radical"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0038836:Superoxide Radical [Element, Ion, or Isotope]
           Superoxide
   804   C0302912:Radical [Chemical Viewed Structurally]
   804   C0439807:Radical [Qualitative Concept]

Phrase: "and"

Phrase: "superoxide dismutases."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038838:superoxide dismutases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0038836:Superoxide [Element, Ion, or Isotope]
Processing 00000000.tx.220: Annu Rev Biochem 64:97112[CrossRef][Medline] Beckman JS, Koppenol WH 1996 Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. 

Phrase: "Annu Rev Biochem 64"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "97112"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Beckman JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Koppenol WH 1996 Nitric oxide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   804   C0030015:oxide [Inorganic Chemical]
   804   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "superoxide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038836:Superoxide [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "peroxynitrite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0136157:Peroxynitrite [Biologically Active Substance,Inorganic Chemical]

Phrase: ":"

Phrase: "the good,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205170:Good [Qualitative Concept]

Phrase: "the bad,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205169:Bad [Qualitative Concept]

Phrase: "and"

Phrase: "ugly."
Processing 00000000.tx.221: Am J Physiol 271:C1424C1437 Lee VM, Goedert M, Trojanowski JQ 2001 Neurodegenerative tauopathies. 

Phrase: "Am"

Phrase: "J Physiol 271"

Phrase: ":"

Phrase: "C1424C1437 Lee VM,"

Phrase: "Goedert M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Trojanowski JQ 2001 Neurodegenerative tauopathies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0949664:Tauopathies [Disease or Syndrome]
Processing 00000000.tx.222: Annu Rev Neurosci 24:11211159[CrossRef][Medline] Spillantini MG, Goedert M 1998 Tau protein pathology in neurodegenerative diseases. 

Phrase: "Annu Rev Neurosci 24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "11211159"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Spillantini MG,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "Goedert M 1998 Tau protein pathology in neurodegenerative diseases."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0030664:Pathology [Biomedical Occupation or Discipline]
   742   C0205469:pathology [Functional Concept]
   742   C0677042:pathology [Pathologic Function]
Processing 00000000.tx.223: Trends Neurosci 21:428433[CrossRef][Medline] Geschwind DH 2003 Tau phosphorylation, tangles, and neurodegeneration: the chicken or the egg? 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci 21"

Phrase: ":"

Phrase: "428433"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Geschwind DH 2003 Tau phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0031715:Phosphorylation [Molecular Function]
   804   C1158886:Phosphorylation [Molecular Function]

Phrase: "tangles,"

Phrase: "and"

Phrase: "neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: ":"

Phrase: "the chicken"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0008051:Chicken [Bird]
  1000   C0677521:Chicken [Food]
  1000   C1365945:CHICKEN [Food]

Phrase: "or"

Phrase: "the egg?"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013710:EGG [Food]
  1000   C0029974:Egg [Cell]
  1000   C1508746:Egg [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.224: Neuron 40:457460[CrossRef][Medline] Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, Gillett N, Stewart TA 1993 IGF-I is required for normal embryonic growth in mice. 

Phrase: "Neuron 40"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0027882:Neuron [Cell]
   861   C0439509:/40 [Temporal Concept]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: ":"

Phrase: "457460"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Powell-Braxton L,"

Phrase: "Hollingshead P,"

Phrase: "Warburton C,"

Phrase: "Dowd M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Pitts-Meek S,"

Phrase: "Dalton D,"

Phrase: "Gillett N,"

Phrase: "Stewart TA 1993 IGF-I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1334089:IGF I [Gene or Genome]
   804   C0021966:I- [Inorganic Chemical]
   804   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "required for normal embryonic growth"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C0018270:embryonic growth? [Organism Function]
           normal growth
           'growth' NOS
   797   C0578019:Normal growth [Finding]
   760   C0013935:Embryonic [Embryonic Structure]
   760   C0205307:Normal [Qualitative Concept]
   760   C0220844:growth [Physiologic Function]
   760   C0439166:% normal [Quantitative Concept]
   760   C1514873:Required [Functional Concept]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2347086:% Normal [Quantitative Concept]
   760   C2911660:Growth [Activity]

Phrase: "in mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.225: Genes Dev 7:26092617[Abstract] Cheng CM, Joncas G, Reinhardt RR, Farrer R, Quarles R, Janssen J, McDonald MP, Crawley JN, Powell-Braxton L, Bondy CA 1998 Biochemical and morphometric analyses show that myelination in the insulin-like growth factor 1 null brain is proportionate to its neuronal composition. 

Phrase: "Genes Dev 7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: ":"

Phrase: "26092617"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Cheng CM,"

Phrase: "Joncas G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Reinhardt RR,"

Phrase: "Farrer R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Quarles R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Janssen J,"

Phrase: "McDonald MP,"

Phrase: "Crawley JN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1428813:JN [Gene or Genome]

Phrase: "Powell-Braxton L,"

Phrase: "Bondy CA 1998 Biochemical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205474:Biochemical [Functional Concept]

Phrase: "and"

Phrase: "morphometric analyses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C0200760:Morphometric analysis [Laboratory Procedure]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that myelination in the insulin-like growth factor 1 null brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0596991:myelination [Cell Function]

Phrase: "is"

Phrase: "proportionate to its neuronal composition."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205351:Proportionate [Qualitative Concept]
   760   C0486616:Composition [Clinical Attribute]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1555710:composition [Idea or Concept]
Processing 00000000.tx.226: J Neurosci 18:56735681[Abstract/Free FullText] Cheng CM, Mervis RF, Niu SL, Salem Jr N, Witters LA, Tseng V, Reinhardt R, Bondy CA 2003 Insulin-like growth factor 1 is essential for normal dendritic growth. 

Phrase: "J Neurosci 18"

Phrase: ":"

Phrase: "56735681"

Phrase: "[Abstract/Free FullText"

Phrase: "] Cheng CM,"

Phrase: "Mervis RF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035448:RF [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0201660:RF [Laboratory Procedure]
   861   C0748398:RF [Finding]

Phrase: "Niu SL,"

Phrase: "Salem Jr N,"

Phrase: "Witters LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Tseng V,"

Phrase: "Reinhardt R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Bondy CA 2003 Insulin-like growth factor 1"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   890   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   890   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   861   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C1753359:insulin-like growth factor [Molecular Function]
   812   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0018270:'growth' NOS [Organism Function]
   793   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C0220844:growth [Physiologic Function]
   793   C1521761:Factor [Functional Concept]
   793   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C1579433:Insulin [Pharmacologic Substance]
   793   C1621966:Growth [Organ or Tissue Function]
   793   C2827422:Factor [Conceptual Entity]
   793   C2911660:Growth [Activity]
   737 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   710 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "essential for normal dendritic growth."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205224:Essential [Qualitative Concept]
Processing 00000000.tx.227: J Neurosci Res 73:19[CrossRef][Medline] Zhou J, Chin E, Bondy C 1991 Cellular pattern of insulin-like growth factor-I (IGF-I) and IGF-I receptor gene expression in the developing and mature ovarian follicle. 

Phrase: "J Neurosci Res 73"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347379:RES [Finding]

Phrase: ":"

Phrase: "19"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zhou J,"

Phrase: "Chin E,"

Phrase: "Bondy C 1991 Cellular pattern of insulin-like growth factor-I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C1156245:Growth pattern [Finding]
   754   C1623229:growth pattern [Cell Function]
   738   C0449774:Pattern [Spatial Concept]

Phrase: "(IGF-I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:IGF I [Gene or Genome]
   861   C0021966:I- [Inorganic Chemical]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: "and"

Phrase: "IGF-I receptor gene expression in the developing"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0017262:Gene Expression [Genetic Function]
   770   C1335671:Receptor Gene [Gene or Genome]
   767   C0597360:receptor expression [Genetic Function]
   744   C0017337:Gene [Gene or Genome]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "mature ovarian follicle."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0682629:mature ovarian follicle [Body Part, Organ, or Organ Component]
   913   C0600225:Mature Follicle [Body Part, Organ, or Organ Component]
   901   C0018120:Ovarian Follicle [Body Part, Organ, or Organ Component]
           Follicle
   901   C1283799:Ovarian follicle [Body Part, Organ, or Organ Component]
   827   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   827   C1571705:Follicle [Body Part, Organ, or Organ Component]
   755 E C0439682:Follicular [Qualitative Concept]
Processing 00000000.tx.228: Endocrinology 129:32813288[Abstract] Wang J, Zhou J, Powell-Braxton L, Bondy C 1999 Effects of Igf1 gene deletion on postnatal growth patterns. 

Phrase: "Endocrinology 129"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "32813288"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Wang J,"

Phrase: "Zhou J,"

Phrase: "Powell-Braxton L,"

Phrase: "Bondy C 1999 Effects of Igf1 gene deletion"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "on postnatal growth patterns."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C1156245:growth patterns [Finding]
   884 E C1623229:growth pattern [Cell Function]
   827   C0449774:Patterns [Spatial Concept]
   734   C0243109:postnatal growth [Organism Function]
Processing 00000000.tx.229: Endocrinology 140:33913394[Abstract/Free FullText] Hoffmann R, Lee VM, Leight S, Varga I, Otvos Jr L 1997 Unique Alzheimers disease paired helical filament specific epitopes involve double phosphorylation at specific sites. 

Phrase: "Endocrinology 140"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "33913394"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hoffmann R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Lee VM,"

Phrase: "Leight S,"

Phrase: "Varga I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Otvos Jr L 1997 Unique Alzheimers disease paired helical filament specific epitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   787   C0003316:Epitopes [Immunologic Factor]

Phrase: "involve"

Phrase: "double phosphorylation at specific sites."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C1519063:Phosphorylation Site [Amino Acid Sequence]
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.230: Biochemistry 36:81148124[CrossRef][Medline] Binder LI, Frankfurter A, Rebhun LI 1985 The distribution of tau in the mammalian central nervous system. 

Phrase: "Biochemistry 36"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: ":"

Phrase: "81148124"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Binder LI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "Frankfurter A,"

Phrase: "Rebhun LI 1985"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "The distribution of tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520511:distribution [Idea or Concept]
   770   C1704711:Distribution [Functional Concept]

Phrase: "in the mammalian central nervous system."
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   923   C0927232:Central Nervous System [Body System]
   923   C1269563:Central nervous system [Body System]
   861   C0027763:Nervous System [Body System]
   861   C0422837:NERVOUS SYSTEM [Finding]
   861   C1269560:Nervous system [Body System]
   812   C0027769:Nervous [Sign or Symptom]
   812   C0205099:Central [Spatial Concept]
   812   C0449913:System [Functional Concept]
   812   C0599851:Nervous [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   812   C1879652:Central - [Laboratory Procedure]
   805 E C0205494:Neurologic [Qualitative Concept]
   768 E C0027855:Neurology [Biomedical Occupation or Discipline]
   750 E C2707261:Neurological [Clinical Attribute]
   741 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.231: J Cell Biol 101:13711378[Abstract] Biernat J, Mandelkow EM, Schroter C, Lichtenberg-Kraag B, Steiner B, Berling B, Meyer H, Mercken M, Vandermeeren A, Goedert M, Mandelkow E 1992 The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region. 

Phrase: "J Cell Biol 101"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "13711378"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Biernat J,"

Phrase: "Mandelkow EM,"

Phrase: "Schroter C,"

Phrase: "Lichtenberg-Kraag B,"

Phrase: "Steiner B,"

Phrase: "Berling B,"

Phrase: "Meyer H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Mercken M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Vandermeeren A,"

Phrase: "Goedert M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Mandelkow E 1992"

Phrase: "The switch of tau protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707719:Switch [Manufactured Object]

Phrase: "to an Alzheimer-"

Phrase: "like state"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1301808:State [Geographic Area]
  1000   C1442792:State [Functional Concept]
  1000   C3148680:State [Geographic Area]

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the phosphorylation of two serine-proline motifs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "upstream of the microtubule binding region."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   913   C1183338:Microtubule region [Cell Component]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]
   734   C1149274:microtubule binding [Molecular Function]
Processing 00000000.tx.232: EMBO J 11:15931597[Abstract] Hasegawa M, Morishima-Kawashima M, Takio K, Suzuki M, Titani K, Ihara Y 1992 Protein sequence and mass spectrometric analyses of tau in the Alzheimers disease brain. 

Phrase: "EMBO J 11"

Phrase: ":"

Phrase: "15931597"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hasegawa M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Morishima-Kawashima M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Takio K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Suzuki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Titani K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Ihara Y 1992 Protein sequence"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   853   C0078671:Y protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0002518:Protein Sequence [Amino Acid Sequence]
   804   C0004793:Sequence [Nucleotide Sequence]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0162326:Sequence [Nucleotide Sequence]
   804   C0162327:Sequence [Nucleotide Sequence]
   804   C1519249:Sequence [Functional Concept]
   733 E C1548958:Sequential [Idea or Concept]
   733 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "mass spectrometric analyses of tau"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0002778:Analysis [Laboratory Procedure]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]

Phrase: "in the Alzheimers disease brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C0002395:Alzheimers disease [Disease or Syndrome]
Processing 00000000.tx.233: J Biol Chem 267:1704717054[Abstract/Free FullText] Morishima-Kawashima M, Hasegawa M, Takio K, Suzuki M, Yoshida H, Watanabe A, Titani K, Ihara Y 1995 Hyperphosphorylation of tau in PHF. 

Phrase: "J Biol Chem 267"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1704717054"

Phrase: "[Abstract/Free FullText"

Phrase: "] Morishima-Kawashima M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Hasegawa M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Takio K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Suzuki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Yoshida H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Watanabe A,"

Phrase: "Titani K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Ihara Y 1995 Hyperphosphorylation of tau"

Phrase: "in PHF."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   890   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   812   C1709450:Paired [Qualitative Concept]
   779   C0010851:Filament [Cell Component]
   729 E C1979891:Filamentous [Qualitative Concept]
Processing 00000000.tx.234: Neurobiol Aging 16:365371[CrossRef][Medline] Nishimura I, Yang Y, Lu B 2004 PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers tau toxicity in Drosophila. 

Phrase: "Neurobiol"

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "16"

Phrase: ":"

Phrase: "365371"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nishimura I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Yang"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "Y,"

Phrase: "Lu B 2004 PAR-1 kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an initiator role in a temporally ordered phosphorylation process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "that"

Phrase: "confers"

Phrase: "tau toxicity in Drosophila."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040539:toxicity [Qualitative Concept]
   770   C0600688:Toxicity [Injury or Poisoning]
Processing 00000000.tx.235: Cell 116:671682[CrossRef][Medline] Billingsley ML, Kincaid RL 1997 Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. 

Phrase: "Cell 116"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "671682"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Billingsley ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Kincaid RL 1997 Regulated phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0031715:Phosphorylation [Molecular Function]
   804   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "dephosphorylation of tau protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1158884:Protein dephosphorylation [Molecular Function]
           Dephosphorylation
   770   C3160734:Dephosphorylation [Molecular Function]

Phrase: ":"

Phrase: "effects on microtubule interaction,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "intracellular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0175996:intracellular [Cell Component]
  1000   C0178719:Intracellular [Spatial Concept]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "and"

Phrase: "neurodegeneration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.236: Biochem J 323(Pt 3):577591 Imahori K, Uchida T 1997 Physiology and pathology of tau protein kinases in relation to Alzheimers disease. 

Phrase: "Biochem J 323"

Phrase: "(Pt 3"

Phrase: ")"

Phrase: ":"

Phrase: "577591 Imahori K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: "Uchida T 1997 Physiology"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0031842:Physiology [Biomedical Occupation or Discipline]
   812   C0031843:physiology [Physiologic Function]
   741 E C0205463:Physiologic [Functional Concept]

Phrase: "and"

Phrase: "pathology of tau protein kinases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030664:Pathology [Biomedical Occupation or Discipline]
   760   C0205469:pathology [Functional Concept]
   760   C0677042:pathology [Pathologic Function]

Phrase: "in relation to Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.237: J Biochem (Tokyo) 121:179188[Abstract] Takashima A, Honda T, Yasutake K, Michel G, Murayama O, Murayama M, Ishiguro K, Yamaguchi H 1998 Activation of tau protein kinase I/glycogen synthase kinase-3 by amyloid  peptide (2535) enhances phosphorylation of tau in hippocampal neurons. 

Phrase: "J Biochem"

Phrase: "(Tokyo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: ")"

Phrase: "121"

Phrase: ":"

Phrase: "179188"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Takashima A,"

Phrase: "Honda T,"

Phrase: "Yasutake K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Michel G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Murayama O,"

Phrase: "Murayama M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ishiguro K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Yamaguchi H 1998 Activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "of tau protein kinase I/glycogen synthase kinase-3"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   892   C2362079:TAU 3 [Immunologic Factor]
   861   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   850   C1515146:I 3 [Cell]
   835   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   793   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "by amyloid  peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(2535"

Phrase: ")"

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "phosphorylation of tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "in hippocampal neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.238: Neurosci Res 31:317323[CrossRef][Medline] Michel G, Mercken M, Murayama M, Noguchi K, Ishiguro K, Imahori K, Takashima A 1998 Characterization of tau phosphorylation in glycogen synthase kinase-3 and cyclin dependent kinase-5 activator (p23) transfected cells. 

Phrase: "Neurosci Res 31"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450355:31 [Intellectual Product]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "317323"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Michel G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Mercken M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Murayama M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Noguchi K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Ishiguro K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Imahori K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Takashima"

Phrase: "A 1998 Characterization of tau phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]

Phrase: "in glycogen synthase kinase-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "cyclin dependent kinase-5 activator"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C2247123:kinase activator [Molecular Function]
   771   C0249586:Cyclin-Dependent Kinase 5 [Amino Acid, Peptide, or Protein,Enzyme]
   771   C1332735:CYCLIN-DEPENDENT KINASE 5 [Gene or Genome]
   717   C0243045:Cyclin-Dependent Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(p23"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0795725:P23 [Organic Chemical,Pharmacologic Substance]
  1000   C1846861:P23 [Gene or Genome]
  1000   C3539715:p23 [Gene or Genome]
  1000   C3539831:p23 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "transfected cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.239: Biochim Biophys Acta 1380:177182[Medline] Summers SA, Birnbaum MJ 1997 A role for the serine/threonine kinase, Akt, in insulin-stimulated glucose uptake. 

Phrase: "Biochim Biophys Acta 1380"

Phrase: ":"

Phrase: "177182"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Summers SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Birnbaum MJ 1997"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439254:MJ [Medical Device]

Phrase: "A role for the serine/threonine kinase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "Akt,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812228:AKT [Gene or Genome]

Phrase: "in insulin-stimulated glucose uptake."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1159527:glucose uptake [Cell Function]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]
Processing 00000000.tx.240: Biochem Soc Trans 25:981988[Medline] Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA 1995 Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. 

Phrase: "Biochem Soc Trans 25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2826298:TRANS [Idea or Concept]

Phrase: ":"

Phrase: "981988"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "Cross"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828360:Cross [Conceptual Entity]

Phrase: "DA,"

Phrase: "Alessi DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "Cohen P,"

Phrase: "Andjelkovich M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hemmings BA 1995 Inhibition of glycogen synthase kinase-3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C3463820:Inhibition [Activity]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "mediated by protein kinase B."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0164786:Protein Kinase B [Amino Acid, Peptide, or Protein,Enzyme]
   862   C0285558:Protein Kinase B [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   797   C0377800:protein B [Amino Acid, Peptide, or Protein,Receptor]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.241: Nature 378:785789[CrossRef][Medline] Cheng CM, Reinhardt RR, Lee WH, Joncas G, Patel SC, Bondy CA 2000 Insulin-like growth factor 1 regulates developing brain glucose metabolism. 

Phrase: "Nature 378"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "785789"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cheng CM,"

Phrase: "Reinhardt RR,"

Phrase: "Lee WH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2349143:Wh [Quantitative Concept]

Phrase: "Joncas G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Patel SC,"

Phrase: "Bondy CA 2000 Insulin-like growth factor 1"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   890   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   890   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   861   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C1753359:insulin-like growth factor [Molecular Function]
   812   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0018270:'growth' NOS [Organism Function]
   793   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C0220844:growth [Physiologic Function]
   793   C1521761:Factor [Functional Concept]
   793   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C1579433:Insulin [Pharmacologic Substance]
   793   C1621966:Growth [Organ or Tissue Function]
   793   C2827422:Factor [Conceptual Entity]
   793   C2911660:Growth [Activity]
   737 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   710 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "regulates"

Phrase: "developing brain glucose metabolism."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0596215:brain metabolism [Organ or Tissue Function]
   861   C0596620:glucose metabolism [Molecular Function]
   812   C0025519:Metabolism [Organism Function]
   812   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.242: Proc Natl Acad Sci USA 97:1023610241[Abstract/Free FullText] Lucas JJ, Hernandez F, Gomez-Ramos P, Moran MA, Hen R, Avila J 2001 Decreased nuclear -catenin, tau hyperphosphorylation and neurodegeneration in GSK-3 conditional transgenic mice. 

Phrase: "Proc Natl Acad Sci USA 97"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C0439073:97 [Intellectual Product]
   799   C0439082:>97 [Quantitative Concept]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "1023610241"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lucas JJ,"

Phrase: "Hernandez F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Gomez-Ramos P,"

Phrase: "Moran MA,"

Phrase: "Hen R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Avila J 2001 Decreased nuclear -catenin,"

Phrase: "tau hyperphosphorylation"

Phrase: "and"

Phrase: "neurodegeneration in GSK-3 conditional transgenic mice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.243: EMBO J 20:2739[Abstract/Free FullText] Hernandez F, Borrell J, Guaza C, Avila J, Lucas JJ 2002 Spatial learning deficit in transgenic mice that conditionally over-express GSK-3 in the brain but do not form tau filaments. 

Phrase: "EMBO J 20"

Phrase: ":"

Phrase: "2739"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hernandez F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Borrell J,"

Phrase: "Guaza C,"

Phrase: "Avila J,"

Phrase: "Lucas JJ 2002 Spatial learning deficit in transgenic mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0162429:Deficit, NOS [Disease or Syndrome]
   742   C2987487:Deficit [Qualitative Concept]

Phrase: "that conditionally"

Phrase: "over-express"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: "GSK-3 in the brain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "but"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "tau filaments."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0010851:Filament [Cell Component]
   777 E C1979891:Filamentous [Qualitative Concept]
Processing 00000000.tx.244: J Neurochem 83:15291533[CrossRef][Medline] Li B, Ryder J, Su Y, Moore Jr SA, Liu F, Solenberg P, Brune K, Fox N, Ni B, Liu R, Zhou Y 2004 Overexpression of GSK3S9A resulted in tau hyperphosphorylation and morphology reminiscent of pretangle-like neurons in the brain of PDGSK3 transgenic mice. 

Phrase: "J Neurochem 83"

Phrase: ":"

Phrase: "15291533"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Li B,"

Phrase: "Ryder J,"

Phrase: "Su Y,"

Phrase: "Moore Jr SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0036243:SA [Geographic Area]
   827   C1539696:SA [Gene or Genome]
   827   C1825840:SA [Gene or Genome]
   827   C3539736:Sa [Spatial Concept]

Phrase: "Liu F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Solenberg P,"

Phrase: "Brune K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Fox N,"

Phrase: "Ni B,"

Phrase: "Liu R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Zhou Y 2004 Overexpression of GSK3S9A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514559:Overexpression [Genetic Function]

Phrase: "resulted in tau hyperphosphorylation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "and"

Phrase: "morphology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0332437:Morphology [Qualitative Concept]
  1000   C0543482:morphology [Spatial Concept]
  1000   C0700329:Morphology, NOS [Finding]
  1000   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "reminiscent of pretangle-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0871247:reminiscence [Mental Process]

Phrase: "like neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of PDGSK3 transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mice, Transgenic [Mammal]
   827   C0003069:Transgenic [Animal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.245: Transgenic Res 13:385396[CrossRef][Medline] Spittaels K, Van den Haute C, Van Dorpe J, Geerts H, Mercken M, Bruynseels K, Lasrado R, Vandezande K, Laenen I, Boon T, Van Lint J, Vandenheede J, Moechars D, Loos R, Van Leuven F 2000 Glycogen synthase kinase-3 phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice. 

Phrase: "Transgenic Res 13"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003069:Transgenic [Animal]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "385396"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Spittaels K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Van den Haute C,"

Phrase: "Van Dorpe J,"

Phrase: "Geerts H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Mercken M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bruynseels K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Lasrado R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Vandezande K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Laenen I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Boon T,"

Phrase: "Van Lint J,"

Phrase: "Vandenheede J,"

Phrase: "Moechars D,"

Phrase: "Loos R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Van Leuven F 2000 Glycogen synthase kinase-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   835   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   793   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "phosphorylates"

Phrase: "protein tau"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1421563:protein tau [Gene or Genome]
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "rescues"

Phrase: "the axonopathy in the central nervous system"

Phrase: "of human four-repeat tau transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025936:Mice, Transgenic [Mammal]
   799   C0003069:Transgenic [Animal]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
Processing 00000000.tx.246: J Biol Chem 275:4134041349[Abstract/Free FullText] Pei J-J, Braak E, Braak H, Iqbal K, Winblad B, Cowburn RF 1999 Distribution of active glycogen synthase kinase 3 (GSK-3) in brains staged for Alzheimer disease neurofibrillary changes. 

Phrase: "J Biol Chem 275"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "4134041349"

Phrase: "[Abstract/Free FullText"

Phrase: "] Pei J-J,"

Phrase: "Braak E,"

Phrase: "Braak H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Iqbal K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Winblad B,"

Phrase: "Cowburn RF 1999 Distribution of active glycogen synthase kinase 3 (GSK-3)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0520511:distribution [Idea or Concept]
   739   C1704711:Distribution [Functional Concept]

Phrase: "in brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "staged for Alzheimer disease neurofibrillary changes."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   809   C0085400:Alzheimer's neurofibrillary change [Acquired Abnormality]
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   783   C0699749:disease staged [Diagnostic Procedure]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   750   C0679846:change stage [Intellectual Product]
   719   C0205390:Stage [Temporal Concept]
   719   C1300072:Stage [Clinical Attribute]
   719   C1306673:Stage [Qualitative Concept]
   719 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.247: J Neuropathol Exp Neurol 58:10101019[Medline] Gotz J, Streffer JR, David D, Schild A, Hoerndli F, Pennanen L, Kurosinski P, Chen F 2004 Transgenic animal models of Alzheimers disease and related disorders: histopathology, behavior and therapy. 

Phrase: "J Neuropathol Exp Neurol 58"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "10101019"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gotz J,"

Phrase: "Streffer JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "David D,"

Phrase: "Schild A,"

Phrase: "Hoerndli F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Pennanen L,"

Phrase: "Kurosinski P,"

Phrase: "Chen F 2004 Transgenic animal models of Alzheimers disease"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   798   C0012644:Animal Model of Disease [Experimental Model of Disease]
           Animal Disease Models
   764   C0003069:Transgenic Animal [Animal]
   764   C0599779:Models, Animal [Animal]
   762   C0003047:animal disease [Disease or Syndrome]
   762   C0683033:disease models [Intellectual Product]
   762   C0684309:disease models [Experimental Model of Disease]
   745   C1519606:Transgenic Model [Experimental Model of Disease]
   742   C0003062:Animal [Animal]
   742   C3161035:Models [Intellectual Product]

Phrase: "and"

Phrase: "related disorders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012634:Disorders [Disease or Syndrome]

Phrase: ":"

Phrase: "histopathology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243140:histopathology [Functional Concept]
  1000   C0677043:Histopathology [Biomedical Occupation or Discipline]

Phrase: "behavior"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0004927:Behavior [Individual Behavior]
  1000   C2707008:Behavior [Clinical Attribute]
   928 E C2986890:Behavioral [Idea or Concept]

Phrase: "and"

Phrase: "therapy."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039798:therapy [Functional Concept]
  1000   C0087111:Therapy [Therapeutic or Preventive Procedure]
  1000   C1363945:Therapy [Finding]
Processing 00000000.tx.248: Mol Psychiatry 9:664683[Medline] Hong M, Lee VM-Y 1997 Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. 

Phrase: "Mol Psychiatry 9"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   827   C0027960:Mole [Neoplastic Process]
   827   C0033872:Psychiatry [Professional or Occupational Group]
   827   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   827   C0324740:Mole [Mammal]
   827   C0439189:Mole [Quantitative Concept]
   827   C1456781:mole [Neoplastic Process]
   827   C1824986:mol [Gene or Genome]
   755 E C0205487:Psychiatric [Functional Concept]
   743 E C0026367:Molar [Body Part, Organ, or Organ Component]
   727 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "664683"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hong M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lee VM-Y 1997 Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin-like growth factor-1"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
  1000   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "regulate"

Phrase: "tau phosphorylation in cultured human neurons."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.249: J Biol Chem 272:1954719553[Abstract/Free FullText] van Dam PS, Aleman A 2004 Insulin-like growth factor-I, cognition and brain aging. 

Phrase: "J Biol Chem 272"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1954719553"

Phrase: "[Abstract/Free FullText"

Phrase: "] van Dam PS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1418867:Ps [Gene or Genome]
   827   C1518860:PS [Geographic Area]
   827   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "Aleman"

Phrase: "A 2004 Insulin-like growth factor-I,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   947   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   848   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0220844:growth [Physiologic Function]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "cognition"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0009240:Cognition [Mental Process]
   916 E C2981149:Intellect [Mental Process]
   907 E C0233698:Noesis [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "brain aging."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0001811:Ageing [Organism Function]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827 E C0001779:Age [Organism Attribute]
Processing 00000000.tx.250: Eur J Pharmacol 490:8795[CrossRef][Medline] Silverman DH, Small GW, Chang CY, Lu CS, Kung De Aburto MA, Chen W, Czernin J, Rapoport SI, Pietrini P, Alexander GE, Schapiro MB, Jagust WJ, Hoffman JM, Welsh-Bohmer KA, Alavi A, Clark CM, Salmon E, de Leon MJ, Mielke R, Cummings JL, Kowell AP, Gambhir SS, Hoh CK, Phelps ME 2001 Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. 

Phrase: "Eur J Pharmacol 490"

Phrase: ":"

Phrase: "8795"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Silverman DH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1832586:DH [Disease or Syndrome]

Phrase: "Small GW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018387:GW [Geographic Area]

Phrase: "Chang CY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010622:CY [Geographic Area]
   861   C0332298:CY [Functional Concept]

Phrase: "Lu CS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540510:cs [Quantitative Concept]

Phrase: "Kung De Aburto MA,"

Phrase: "Chen W,"

Phrase: "Czernin J,"

Phrase: "Rapoport SI,"

Phrase: "Pietrini P,"

Phrase: "Alexander GE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538705:GE [Gene or Genome]

Phrase: "Schapiro MB,"

Phrase: "Jagust WJ,"

Phrase: "Hoffman JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Welsh-Bohmer KA,"

Phrase: "Alavi A,"

Phrase: "Clark CM,"

Phrase: "Salmon E,"

Phrase: "de Leon MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439254:MJ [Medical Device]

Phrase: "Mielke R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Cummings JL,"

Phrase: "Kowell AP,"

Phrase: "Gambhir SS,"

Phrase: "Hoh CK,"

Phrase: "Phelps"

Phrase: "ME 2001 Positron emission tomography in evaluation of dementia"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0032743:Positron-Emission Tomography [Diagnostic Procedure]
   742   C0032744:Positron [Quantitative Concept]
   742   C0040395:tomography [Diagnostic Procedure]
   742   C0040405:tomography [Diagnostic Procedure]
   742   C0233929:Emission [Body Substance]
   742   C2349995:Emission [Substance]

Phrase: ":"

Phrase: "regional brain metabolism"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0596215:brain metabolism [Organ or Tissue Function]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
   827   C0205147:regional [Spatial Concept]
   827   C0205276:Regional [Spatial Concept]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "long-term outcome."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1274040:Outcome [Functional Concept]
   734   C0443252:Long-term [Temporal Concept]
Processing 00000000.tx.251: JAMA 286:21202127[Abstract/Free FullText] Hoyer S 2004 Glucose metabolism and insulin receptor signal transduction in Alzheimer disease. 

Phrase: "JAMA 286"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1422839:JAMA [Gene or Genome]

Phrase: ":"

Phrase: "21202127"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hoyer S 2004 Glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0596620:glucose metabolism [Molecular Function]
   804   C0025519:Metabolism [Organism Function]
   804   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "insulin receptor signal transduction in Alzheimer disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0037083:Signal Transduction [Cell Function]
   748   C1160185:transduction [Organism Function]
   748   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.252: Eur J Pharmacol 490:115125[CrossRef][Medline] Carro E, Torres-Aleman I 2004 The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimers disease. 

Phrase: "Eur J Pharmacol 490"

Phrase: ":"

Phrase: "115125"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Carro E,"

Phrase: "Torres-Aleman I 2004"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "The role of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "insulin-like growth factor I in the molecular"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   869   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   869   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   833   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   833   C1753359:insulin-like growth factor [Molecular Function]
   770   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0021966:I- [Inorganic Chemical]
   744   C0220844:growth [Physiologic Function]
   744   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C1521761:Factor [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]
   739   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "cellular mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "underlying"

Phrase: "the pathology of Alzheimers disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030664:Pathology [Biomedical Occupation or Discipline]
   760   C0205469:pathology [Functional Concept]
   760   C0677042:pathology [Pathologic Function]
Processing 00000000.tx.253: Eur J Pharmacol 490:127133[CrossRef][Medline] Breese CR, Ingram RL, Sonntag WE 1991 Influence of age and long-term dietary restriction on plasma insulin-like growth factor-1 (IGF-1), IGF-1 gene expression, and IGF-1 binding proteins. 

Phrase: "Eur J Pharmacol 490"

Phrase: ":"

Phrase: "127133"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Breese CR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0201975:Cr [Laboratory Procedure]
   861   C3539604:CR [Gene or Genome]

Phrase: "Ingram RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "Sonntag"

Phrase: "WE 1991 Influence of age"

Phrase: "and"

Phrase: "long-term dietary restriction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0425422:dietary restriction [Finding]
   812   C0012155:Dietary [Food]
   812   C0443288:Restriction [Functional Concept]
   812   C2699635:DIETARY [Functional Concept]

Phrase: "on plasma insulin-like growth factor-1 (IGF-1),"
Meta Candidates (Total=21; Excluded=2; Pruned=0; Remaining=19)
   913   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   877   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   877   C1753359:insulin-like growth factor [Molecular Function]
   818   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0857690:plasma insulin [Laboratory Procedure]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0032105:Plasma [Body Substance]
   795   C0220844:growth [Physiologic Function]
   795   C1521761:Factor [Functional Concept]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C1720176:On [Functional Concept]
   795   C1720294:On [Intellectual Product]
   795   C2827422:Factor [Conceptual Entity]
   795   C2911660:Growth [Activity]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "IGF-1 gene expression,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   877   C1337112:Insulin Gene [Gene or Genome]
   852   C0812325:Growth Factor Gene [Gene or Genome]
   818   C0017262:Gene Expression [Genetic Function]
   795   C0017337:Gene [Gene or Genome]
   795   C0185117:Expression [Therapeutic or Preventive Procedure]
   747   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   747   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   710   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   710   C1753359:insulin-like growth factor [Molecular Function]

Phrase: "and"

Phrase: "IGF-1 binding proteins."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   934   C0074825:Insulin-Like Growth-Factor-Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   911   C1149301:insulin-like growth factor binding [Molecular Function]
   877   C1623517:insulin binding [Molecular Function]
   852   C1149299:Growth Factor Binding [Molecular Function]
   818   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0243122:binding [Functional Concept]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]
   747   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   747   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   710   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   710   C1753359:insulin-like growth factor [Molecular Function]
Processing 00000000.tx.254: J Gerontol 46:B180B187 Lai M, Hibberd CJ, Gluckman PD, Seckl JR 2000 Reduced expression of insulin-like growth factor 1 messenger RNA in the hippocampus of aged rats. 

Phrase: "J Gerontol 46"

Phrase: ":"

Phrase: "B180B187 Lai M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Hibberd CJ,"

Phrase: "Gluckman PD,"

Phrase: "Seckl JR 2000 Reduced expression of insulin-like growth factor 1 messenger RNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   749   C0040649:RNA Expression [Genetic Function]
   735   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "of aged rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.255: Neurosci Lett 288:6670[CrossRef][Medline] Sonntag WE, Lynch CD, Bennett SA, Khan AS, Thornton PL, Cooney PT, Ingram RL, McShane T, Brunso-Bechtold JK 1999 Alterations in insulin-like growth factor-1 gene and protein expression and type 1 insulin-like growth factor receptors in the brains of ageing rats. 

Phrase: "Neurosci Lett 288"

Phrase: ":"

Phrase: "6670"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sonntag"

Phrase: "WE,"

Phrase: "Lynch CD,"

Phrase: "Bennett SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Khan AS,"

Phrase: "Thornton PL,"

Phrase: "Cooney PT,"

Phrase: "Ingram RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "McShane T,"

Phrase: "Brunso-Bechtold JK 1999 Alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1515926:Alteration [Idea or Concept]

Phrase: "in insulin-like growth factor-1 gene"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   895   C1337112:Insulin Gene [Gene or Genome]
   867   C0812325:Growth Factor Gene [Gene or Genome]
   799   C0017337:Gene [Gene or Genome]
   780   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   780   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   734   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   734   C1753359:insulin-like growth factor [Molecular Function]

Phrase: "and"

Phrase: "protein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1171362:protein expression [Genetic Function]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "type 1 insulin-like growth factor receptors in the brains"
Meta Candidates (Total=28; Excluded=1; Pruned=0; Remaining=27)
   853   C0140080:Receptor, Insulin-Like Growth Factor Type 1 [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
           Insulin-Like Growth Factor 1 Receptor
   833   C0140079:Insulin-Like Growth Factor Receptors [Amino Acid, Peptide, or Protein,Receptor]
   831   C1334088:insulin-like growth factor 1 receptor [Gene or Genome]
   824   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   824   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   806   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   806   C1753359:insulin-like growth factor [Molecular Function]
   782   C0206454:Growth Factor Receptors [Amino Acid, Peptide, or Protein,Receptor]
   764   C0290266:Brain Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0812297:BRAIN FACTOR 1 [Gene or Genome]
   760   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0441729:Type 1 [Classification]
   757   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   757   C0457592:Insulin type [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   741 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   739   C0018270:'growth' NOS [Organism Function]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0220844:growth [Physiologic Function]
   739   C0332307:Type [Qualitative Concept]
   739   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   739   C1521761:Factor [Functional Concept]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1547052:*Type [Quantitative Concept]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C1621966:Growth [Organ or Tissue Function]
   739   C2827422:Factor [Conceptual Entity]
   739   C2911660:Growth [Activity]

Phrase: "of ageing rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.256: Neuroscience 88:269279[CrossRef][Medline] This Article Abstract Full Text (PDF) All Versions of this Article: 146/12/5086 most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Google Scholar Articles by Cheng, C. 

Phrase: "Neuroscience 88"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: ":"

Phrase: "269279"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "This Article Abstract Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1527021:Text [Intellectual Product]
   812   C1554111:Text [Idea or Concept]
   812   C1705606:Text [Intellectual Product]
   812   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "146/12/5086 most recent Author Manuscript"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0600659:Manuscript [Intellectual Product,Manufactured Object]

Phrase: "(PDF) Purchase Article View Shopping Cart"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441061:Shopping cart [Manufactured Object]
   799   C0179636:Cart [Manufactured Object]
   799   C1824528:CART [Gene or Genome]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Citation Map Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0557854:Services [Occupational Activity]
   793 E C2825316:Service [Manufactured Object]
   793 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal Download"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0162443:Journal [Intellectual Product,Manufactured Object]
   744   C0205314:New [Temporal Concept]
   711   C0033213:Issue [Finding]
   711   C1706387:Issue [Intellectual Product]

Phrase: "to citation manager Request Copyright Permission Google Scholar Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1706852:Article [Intellectual Product]

Phrase: "by Cheng,"

Phrase: "C."
Processing 00000000.tx.257: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.258: Articles by Bondy, C. 

Phrase: "Articles by Bondy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "C."
Processing 00000000.tx.259: A. 

Phrase: "A."
Processing 00000000.tx.260: PubMed PubMed Citation Articles by Cheng, C. 

Phrase: "PubMed PubMed Citation Articles by Cheng,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1706852:Article [Intellectual Product]

Phrase: "C."
Processing 00000000.tx.261: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.262: Articles by Bondy, C. 

Phrase: "Articles by Bondy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "C."
Processing 00000000.tx.263: A. 

Phrase: "A."
Processing 00000000.tx.264: HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS Endocrinology Endocrine Reviews J. 

Phrase: "HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS Endocrinology Endocrine Reviews J."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   735   C0039224:Table [Manufactured Object]
   735   C1706073:Table [Medical Device]
   735   C1706074:Table [Intellectual Product]
Processing 00000000.tx.265: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.266: End. 

Phrase: "End."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.267: & Metab. 

Phrase: "& Metab."
Processing 00000000.tx.268: Molecular Endocrinology Recent Prog. 

Phrase: "Molecular Endocrinology Recent Prog."
Processing 00000000.tx.269: Horm. 

Phrase: "Horm."
Processing 00000000.tx.270: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.271: All Endocrine Journals

Phrase: "All Endocrine Journals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0162443:journals [Intellectual Product,Manufactured Object]

